{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:12:32Z","timestamp":1790835152557,"version":"4.1.0"},"reference-count":903,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Dr M\u00e9lanie Lagi\u00e8re for help with editing"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neurobiology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.pneurobio.2016.03.004","type":"journal-article","created":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T05:16:22Z","timestamp":1458623782000},"page":"175-236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":153,"special_numbering":"C","title":["Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications"],"prefix":"10.1016","volume":"151","author":[{"given":"Philippe","family":"De Deurwaerd\u00e8re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Di Giovanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pneurobio.2016.03.004_bib0005","doi-asserted-by":"crossref","first-page":"8156","DOI":"10.1523\/JNEUROSCI.3905-08.2009","article-title":"Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway function","volume":"29","author":"Abdallah","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0010","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/0028-3908(95)00138-7","article-title":"Localization of the 5-hydroxytryptamine(2C) receptor protein in human and rat brain using specific antisera","volume":"34","author":"Abramowski","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0015","series-title":"Proceedings of the IX Congress of the College of International Neuropsychopharmacology","first-page":"444","article-title":"DA-ergic and nonDA-ergic neurons of the substantia nigra: differential responses to putative transmitters","author":"Aghajanian","year":"1974"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0020","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1212\/WNL.50.4.858","article-title":"Levodopa: is toxicity a myth?","volume":"50","author":"Agid","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0025","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0028-3908(03)00304-6","article-title":"Regulation by 5-HT1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex","volume":"45","author":"Ago","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/sj.npp.1300567","article-title":"Sulpiride in combination with fluvoxamine increases in vivo dopamine release selectively in rat prefrontal cortex","volume":"30","author":"Ago","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0035","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/026988119801200304","article-title":"Repeated administration of fluoxetine: desipramine and tranylcypromine increases dopamine D2-like but not D1-like receptor function in the rat","volume":"12","author":"Ainsworth","year":"1998","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0040","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0045","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pharmthera.2006.08.004","article-title":"Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission","volume":"113","author":"Alex","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0050","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/syn.20109","article-title":"Modulation of dopamine release by striatal 5-HT2C receptors","volume":"55","author":"Alex","year":"2005","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0055","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1111\/j.1743-6109.2010.01763.x","article-title":"Acute and repeated flibanserin administration in female rats modulates monoamines differentially across brain areas: a microdialysis study","volume":"7","author":"Allers","year":"2010","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0060","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1124\/jpet.106.111690","article-title":"D2-like dopamine receptors depolarize dorsal raphe serotonin neurons through the activation of nonselective cationic conductance","volume":"320","author":"Aman","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/cercor\/bhg128","article-title":"Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex","volume":"14","author":"Amargos-Bosch","year":"2004","journal-title":"Cerebral Cortex (New York N.Y.: 1991)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0070","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejphar.2005.05.004","article-title":"Effects of acute olanzapine after sustained fluoxetine on extracellular monoamine levels in the rat medial prefrontal cortex","volume":"516","author":"Amargos-Bosch","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0075","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1523\/JNEUROSCI.5196-09.2010","article-title":"VGLUT3 (vesicular glutamate transporter type 3) contribution to the regulation of serotonergic transmission and anxiety","volume":"30","author":"Amilhon","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0080","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/BF00172774","article-title":"Ritanserin potentiates the stimulatory effects of raclopride on neuronal-Activity and dopamine release selectively in the mesolimbic dopaminergic system","volume":"352","author":"Andersson","year":"1995","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0085","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/BF00172774","article-title":"Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system","volume":"352","author":"Andersson","year":"1995","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0090","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1471-4159.1978.tb06551.x","article-title":"The effects of 5-hydroxytryptophan and 5-hydroxytryptamine on dopamine synthesis and release in rat brain striatal synaptosomes","volume":"30","author":"Andrews","year":"1978","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0095","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0304-3940(95)11817-G","article-title":"L-DOPA is converted to dopamine in serotonergic fibers of the striatum of the rat: a double-labeling immunofluorescence study","volume":"195","author":"Arai","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0006-8993(95)01281-8","article-title":"Aromatic L-amino acid decarboxylase is present in serotonergic fibers of the striatum of the rat: a double-labeling immunofluorescence study","volume":"706","author":"Arai","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0105","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF00165384","article-title":"The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301: differentially affect the activity of midbrain dopamine neurons","volume":"347","author":"Arborelius","year":"1993","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF02245056","article-title":"Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys","volume":"116","author":"Arnsten","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"issue":"Suppl. (2)","key":"10.1016\/j.pneurobio.2016.03.004_bib0115","first-page":"123","article-title":"Mechanism of action of antidepressants","volume":"36","author":"Artigas","year":"2002","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0120","article-title":"Developments in the field of antidepressants, where do we go now?","author":"Artigas","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0125","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/(SICI)1098-2396(199612)24:4<349::AID-SYN5>3.0.CO;2-D","article-title":"Pharmacological actions of the atypical antipsychotic drug clozapine: a review","volume":"24","author":"Ashby","year":"1996","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0130","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0014-2999(90)90574-P","article-title":"Chronic Brl-43694 a selective 5-Ht3 receptor antagonist fails to alter the number of spontaneously active midbrain dopamine neurons","volume":"175","author":"Ashby","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0135","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/jpet.105.087163","article-title":"Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain","volume":"315","author":"Assie","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0140","doi-asserted-by":"crossref","first-page":"9150","DOI":"10.1523\/JNEUROSCI.22-21-09150.2002","article-title":"D-amphetamine fails to increase extracellular dopamine levels in mice lacking alpha 1b-adrenergic receptors: relationship between functional and nonfunctional dopamine release","volume":"22","author":"Auclair","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0145","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1471-4159.2004.02714.x","article-title":"Role of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: comparison with previous data on alpha1b-adrenergic receptors","volume":"91","author":"Auclair","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0150","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/j.1471-4159.2010.06848.x","article-title":"The central serotonin 2B receptor: a new pharmacological target to modulate the mesoaccumbens dopaminergic pathway activity","volume":"114","author":"Auclair","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0155","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/cne.901790311","article-title":"An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat","volume":"179","author":"Azmitia","year":"1978","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0160","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1017\/S1461145701002632","article-title":"Anxiety-like effects induced by acute fluoxetine: sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635","volume":"4","author":"Bagdy","year":"2001","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0165","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0022-3565(24)37337-9","article-title":"Dexfenfluramine enhances striatal dopamine release in conscious rats via a serotoninergic mechanism","volume":"284","author":"Balcioglu","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0170","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0893-133X(01)00345-1","article-title":"Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B\/1D) and 5-HT(2) receptors","volume":"26","author":"Bankson","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0175","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1471-4159.2004.02763.x","article-title":"Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release","volume":"91","author":"Bankson","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0180","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0031-6997(25)06572-X","article-title":"Pharmacology of mesocortical dopamine neurons","volume":"35","author":"Bannon","year":"1983","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0185","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0026-895X(25)13249-5","article-title":"5-hydroxytryptamine1C receptor density and mRNA levels in choroid plexus epithelial cells after treatment with mianserin and (?)-1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane","volume":"44","author":"Barker","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0190","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/jnnp.70.6.727","article-title":"Visual hallucinations in Parkinson\u2019s disease: a review and phenomenological survey","volume":"70","author":"Barnes","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0195","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0200","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0028-3908(90)90110-D","article-title":"Characterization and autoradiographic localization of 5-Ht3 receptor recognition sites identified with [3 h]-(S)-Zacopride in the forebrain of the rat","volume":"29","author":"Barnes","year":"1990","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0205","doi-asserted-by":"crossref","first-page":"14094","DOI":"10.1523\/JNEUROSCI.3370-12.2012","article-title":"2012: Braking dopamine systems: a new GABA master structure for mesolimbic and nigrostriatal functions","volume":"32","author":"Barrot","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0210","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1091\/mbc.E06-12-1080","article-title":"5- hydroxytryptamine 4 receptor activation of the extracellular signal-regulated kinase pathway depends on Src activation but not on G protein or beta-arrestin signaling","volume":"18","author":"Barthet","year":"2007","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0215","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.07.002","article-title":"Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson\u2019s disease","volume":"132","author":"Bastide","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0220","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0165-6147(00)88991-9","article-title":"5-HT2 receptor subtypes: a family re-united?","volume":"16","author":"Baxter","year":"1995","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0225","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.2042-7158.1982.tb04801.x","article-title":"5-Hydroxytryptamine and 5-hydroxytryptaminergic-dopaminergic interactions in the ventral tegmental area of rat brain","volume":"34","author":"Beart","year":"1982","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0230","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.neuron.2007.12.019","article-title":"Cocaine seeking habits depend upon dopamine-dependent serial connectivity linking the ventral with the dorsal striatum","volume":"57","author":"Belin","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(91)90658-D","article-title":"Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis","volume":"200","author":"Benloucif","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0240","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0022-3565(25)38133-4","article-title":"Serotonin-facilitated dopamine release in vivo: pharmacological characterization","volume":"265","author":"Benloucif","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0245","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0014-2999(98)00586-X","article-title":"5-HT-moduline a 5-HT(1B\/1D) receptor endogenous modulator, interacts with dopamine release measured in vivo by microdialysis","volume":"358","author":"Bentue-Ferrer","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0250","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/BF00164581","article-title":"Dopamine releasing effect of phenylbiguanide in rat striatal slices","volume":"345","author":"Benuck","year":"1992","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0255","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1124\/jpet.106.104448","article-title":"Differential effects of 5-methyl-1-[[2-[(2-methyl-3-pyridyl) oxyl]-5-pyridyl]carbamoyl]-6-trifluoro methylindone (SB 243213) on 5-hydroxytryptamine(2C) receptor-mediated responses","volume":"319","author":"Berg","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0260","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.neuropharm.2008.06.014","article-title":"Fine-tuning serotonin2c receptor function in the brain: molecular and functional implications","volume":"55","author":"Berg","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0265","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0014-2999(92)90023-W","article-title":"The substituted amphetamines 3,4-methylenedioxymethamphetamine methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine","volume":"215","author":"Berger","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0270","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00002826-199012000-00003","article-title":"5-HT2 antagonist ritanserin in neuroleptic-induced parkinsonism: a double-blind comparison with orphenadrine and placebo","volume":"13","author":"Bersani","year":"1990","journal-title":"Clin. Neuropharmacol."},{"issue":"Suppl. (1)","key":"10.1016\/j.pneurobio.2016.03.004_bib0275","first-page":"90","article-title":"[Demonstration of the liberation of dopamine (DA) and serotonin (5HT) at the caudate nucleus level in the rat]","volume":"61","author":"Besson","year":"1969","journal-title":"J. Physiol. (Paris)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0280","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neuroscience.2010.04.061","article-title":"Stimulation of serotonin2C receptors elicits abnormal oral movements by acting on pathways other than the sensorimotor one in the rat basal ganglia","volume":"169","author":"Beyeler","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0285","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.nbd.2006.02.003","article-title":"5-HT1A receptor agonist-mediated protection from MPTP toxicity in mouse and macaque models of Parkinson\u2019s disease","volume":"23","author":"Bezard","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0290","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/mds.25366","article-title":"Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia","volume":"28","author":"Bezard","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0295","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1111\/j.1460-9568.2012.08202.x","article-title":"Serotonin transporter inhibition attenuates l-DOPA-induced dyskinesia without compromising l-DOPA efficacy in hemi-parkinsonian rats","volume":"36","author":"Bishop","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0300","series-title":"Handbook of Physiology. The Nervous System. IV. Intrinsic Regulatory Systems of the Brain","first-page":"677","article-title":"Catecholaminergic brain stem regulatory systems","author":"Bj\u00f6rklund","year":"1986"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0305","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.tins.2007.03.006","article-title":"Dopamine neuron systems in the brain: an update","volume":"30","author":"Bjorklund","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0310","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/syn.10116","article-title":"Effect of acute and chronic administration of the selective 5-HT(2C) receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study","volume":"46","author":"Blackburn","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0315","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/syn.10116","article-title":"Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study","volume":"46","author":"Blackburn","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0320","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/syn.20263","article-title":"The acute and chronic administration of the 5-HT(2B\/2C) receptor antagonist SB-200646A significantly alters the activity of spontaneously active midbrain dopamine neurons in the rat: an in vivo extracellular single cell study","volume":"59","author":"Blackburn","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0325","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0022-3565(25)21081-3","article-title":"Release of endogenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in rat striatum","volume":"251","author":"Blandina","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0330","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0006-8993(76)90050-0","article-title":"The raphe nuclei of the cat brain stem: a topographical atlas of their efferent projections as revealed by autoradiography","volume":"113","author":"Bobillier","year":"1976","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0335","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0026-895X(25)10829-8","article-title":"Pharmacological characterization of 5-hydroxytryptamine4(5-HT4) receptors positively coupled to adenylate cyclase in adult guinea pig hippocampal membranes: effect of substituted benzamide derivatives","volume":"37","author":"Bockaert","year":"1990","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0340","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0028-3908(94)90059-0","article-title":"Molecular-Biology of 5-Ht receptors","volume":"33","author":"Boess","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0345","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0893-133X(02)00311-1","article-title":"SR46349-B a 5-HT(2A\/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens","volume":"27","author":"Bonaccorso","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0350","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0306-4522(97)00302-3","article-title":"Detailed mapping of serotonin 5-HT1B and 5-HT1D receptor messenger RNA and ligand binding sites in guinea-pig brain and trigeminal ganglion: clues for function","volume":"82","author":"Bonaventure","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0355","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/(SICI)1098-2396(200004)36:1<35::AID-SYN4>3.0.CO;2-Y","article-title":"Mapping of serotonin 5-HT(4) receptor mRNA and ligand binding sites in the post-mortem human brain","volume":"36","author":"Bonaventure","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0360","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0006-8993(02)02504-0","article-title":"Nuclei and subnuclei gene expression profiling in mammalian brain","volume":"943","author":"Bonaventure","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0365","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejphar.2005.03.013","article-title":"Molecular and pharmacological characterization of serotonin 5-HT2A and 5-HT2B receptor subtypes in dog","volume":"513","author":"Bonaventure","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0370","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1476-5381.1995.tb14977.x","article-title":"The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors","volume":"115","author":"Bonhaus","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0375","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0028-3908(94)00145-I","article-title":"Evidence for 5-HT4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rat","volume":"34","author":"Bonhomme","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0380","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00002826-199402000-00008","article-title":"Buspirone in levodopa-induced dyskinesias","volume":"17","author":"Bonifati","year":"1994","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0385","doi-asserted-by":"crossref","first-page":"8596","DOI":"10.1523\/JNEUROSCI.17-21-08596.1997","article-title":"Systemic morphine-induced Fos protein in the rat striatum and nucleus accumbens is regulated by mu opioid receptors in the substantia nigra and ventral tegmental area","volume":"17","author":"Bontempi","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0390","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/sj.bjp.0706935","article-title":"In vivo evidence that 5-HT(2C) receptors inhibit 5-HT neuronal activity via a GABAergic mechanism","volume":"149","author":"Boothman","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0395","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1177\/0269881115573804","article-title":"Effects of ST1936 a selective serotonin-6 agonist, on electrical activity of putative mesencephalic dopaminergic neurons in the rat brain","volume":"29","author":"Borsini","year":"2015","journal-title":"J. Psychopharmacol. (Oxf.)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0400","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/j.1471-4159.2005.03485.x","article-title":"The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity","volume":"95","author":"Bortolozzi","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0405","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00213-007-0698-y","article-title":"In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain","volume":"191","author":"Bortolozzi","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0410","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0028-3908(96)00099-8","article-title":"Modulation of dopamine release in the nucleus accumbens by 5-HT1B agonists: involvement of the hippocampo-accumbens pathway","volume":"35","author":"Boulenguez","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0415","doi-asserted-by":"crossref","first-page":"9575","DOI":"10.1523\/JNEUROSCI.3465-08.2008","article-title":"Behavioral recovery in MPTP-treated monkeys: neurochemical mechanisms studied by intrastriatal microdialysis","volume":"28","author":"Boulet","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0420","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0306-4522(87)90008-X","article-title":"A detailed mapping of dopamine D-2 receptors in rat central nervous system by autoradiography with [125I]iodosulpride","volume":"20","author":"Bouthenet","year":"1987","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0425","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1046\/j.1471-4159.2000.0751625.x","article-title":"Serotonin 5-HT(2) receptor stimulation of dopamine release in the posterior but not anterior nucleus accumbens of the rat","volume":"75","author":"Bowers","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0430","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1073\/pnas.0811507106","article-title":"Phasic excitation of dopamine neurons in ventral VTA by noxious stimuli","volume":"106","author":"Brischoux","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0435","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1152\/jn.1996.76.3.2077","article-title":"Serotonin potentiates dopamine inhibition of ventral tegmental area neurons in vitro","volume":"76","author":"Brodie","year":"1996","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0440","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.neuron.2010.11.022","article-title":"Dopamine in motivational control: rewarding aversive, and alerting","volume":"68","author":"Bromberg-Martin","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0445","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01245227","article-title":"Dopamine and depression","volume":"91","author":"Brown","year":"1993","journal-title":"J. Neural Transm. Gen. Sect."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0450","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1523\/JNEUROSCI.4423-08.2009","article-title":"Activity of neurochemically heterogeneous dopaminergic neurons in the substantia nigra during spontaneous and driven changes in brain state","volume":"29","author":"Brown","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0455","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/BF00166939","article-title":"Autoradiographic characterization and localization of 5-Ht(1d) compared to 5-Ht(1b) binding-Sites in rat-Brain","volume":"347","author":"Bruinvels","year":"1993","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0460","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0028-3908(94)90067-1","article-title":"Localization of 5-HT1B 5-HT1D alpha 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain","volume":"33","author":"Bruinvels","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0465","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.neuroscience.2006.12.071","article-title":"Distribution of serotonin 5-HT2C receptors in the ventral tegmental area","volume":"146","author":"Bubar","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0470","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0079-6123(08)00916-3","article-title":"Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse","volume":"172","author":"Bubar","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0475","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0028-3908(02)00381-7","article-title":"Selective serotonin reuptake inhibitors enhance cocaine-induced locomotor activity and dopamine release in the nucleus accumbens","volume":"44","author":"Bubar","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0480","doi-asserted-by":"crossref","first-page":"e20508","DOI":"10.1371\/journal.pone.0020508","article-title":"5-HT(2C) receptors localize to dopamine and GABA neurons in the rat mesoaccumbens pathway","volume":"6","author":"Bubar","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0485","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/newbio245123a0","article-title":"Comparison of effects of L-dopa: amphetamine and apomorphine on firing rate of rat dopaminergic neurones","volume":"245","author":"Bunney","year":"1973","journal-title":"Nat. New Biol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0490","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0022-3565(25)29539-8","article-title":"Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity","volume":"185","author":"Bunney","year":"1973","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0495","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0022-3565(24)39246-8","article-title":"Cocaine potentiates ethanol-induced excitation of dopaminergic reward neurons in the ventral tegmental area","volume":"293","author":"Bunney","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0500","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/jnc.12842","article-title":"Striatal serotonin 2C receptors decrease nigrostriatal dopamine release by increasing GABA-A receptor tone in the substantia nigra","volume":"131","author":"Burke","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0505","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/387303a0","article-title":"Regulation of serotonin-2C receptor G-protein coupling by RNA editing","volume":"387","author":"Burns","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0510","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s002130050142","article-title":"Stress: depression and the mesolimbic dopamine system","volume":"128","author":"Cabib","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0515","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0306-4522(94)00507-2","article-title":"Role of vesicular dopamine in the in vivo stimulation of striatal dopamine transmission by amphetamine: evidence from microdialysis and Fos immunohistochemistry","volume":"65","author":"Cadoni","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0520","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1523\/JNEUROSCI.14-11-06763.1994","article-title":"Cocaine inhibits GABA release in the VTA through endogenous 5-HT","volume":"14","author":"Cameron","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0525","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1440-1681.1995.tb01947.x","article-title":"Opposing roles for dopamine and serotonin at presynaptic receptors in the ventral tegmental area","volume":"22","author":"Cameron","year":"1995","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0530","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0306-4522(96)00444-7","article-title":"A subset of ventral tegmental area neurons is inhibited by dopamine: 5-hydroxytryptamine and opioids","volume":"77","author":"Cameron","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0535","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0091-3057(95)00050-7","article-title":"Serotonin-3 receptor and ethanol-stimulated dopamine release in the nucleus accumbens","volume":"51","author":"Campbell","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0540","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0741-8329(96)00069-9","article-title":"Serotonin-3 receptor and ethanol-stimulated somatodendritic dopamine release","volume":"13","author":"Campbell","year":"1996","journal-title":"Alcohol"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0545","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0014-2999(89)90259-8","article-title":"Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine release","volume":"164","author":"Carboni","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0550","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0166-2236(90)90108-M","article-title":"Interactions between glutamatergic and monoaminergic systems within the basal ganglia\u2013implications for schizophrenia and Parkinson\u2019s disease","volume":"13","author":"Carlsson","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0555","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/brain\/awm082","article-title":"Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats","volume":"130","author":"Carta","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0560","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0079-6123(08)00922-9","article-title":"Serotonin-dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias","volume":"172","author":"Carta","year":"2008","journal-title":"Prog. Brain Res."},{"issue":"Suppl (1)","key":"10.1016\/j.pneurobio.2016.03.004_bib0565","doi-asserted-by":"crossref","first-page":"S174","DOI":"10.1002\/mds.22792","article-title":"Role of serotonin neurons in the induction of levodopa- and graft-induced dyskinesias in Parkinson\u2019\u2019\u2019s disease","volume":"25","author":"Carta","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0570","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0006-8993(80)91016-1","article-title":"Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat","volume":"192","author":"Carter","year":"1980","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0575","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/adb.12137","article-title":"Serotonin2C receptors modulate dopamine transmission in the nucleus accumbens independently of dopamine release: behavioral, neurochemical and molecular studies with cocaine","volume":"20","author":"Cathala","year":"2015","journal-title":"Addict. Biol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0580","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s40263-013-0071-0","article-title":"Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research","volume":"27","author":"Celada","year":"2013","journal-title":"CNS drugs"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0585","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/0028-3908(87)90165-1","article-title":"Evidence that dopamine mechanisms in the nucleus accumbens are selectively involved in the effect of desipramine in the forced swimming test","volume":"26","author":"Cervo","year":"1987","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0590","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.2042-7158.1988.tb05208.x","article-title":"Repeated treatment with imipramine and amitriptyline reduced the immobility of rats in the swimming test by enhancing dopamine mechanisms in the nucleus accumbens","volume":"40","author":"Cervo","year":"1988","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0595","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0014-2999(90)94805-8","article-title":"The role of the mesolimbic dopaminergic system in the desipramine effect in the forced swimming test","volume":"178","author":"Cervo","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0600","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0091-3057(96)00046-9","article-title":"5-HT3 receptor antagonists do not modify cocaine place conditioning or the rise in extracellular dopamine in the nucleus accumbens of rats","volume":"55","author":"Cervo","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0605","doi-asserted-by":"crossref","first-page":"e1317","DOI":"10.1371\/journal.pone.0001317","article-title":"Modifying ligand-induced and constitutive signaling of the human 5-HT4 receptor","volume":"2","author":"Chang","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0610","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1046\/j.1471-4159.1995.64041585.x","article-title":"Monoamine interactions measured by microdialysis in the ventral tegmental area of rats treated systemically with (+\/?)-8-hydroxy-2-(di-n-propylamino) tetralin","volume":"64","author":"Chen","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0615","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0006-8993(91)90050-6","article-title":"Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens","volume":"543","author":"Chen","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0620","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/syn.890100308","article-title":"Presynaptic dopamine release is enhanced by 5-HT3 receptor activation in medial prefrontal cortex of freely moving rats","volume":"10","author":"Chen","year":"1992","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0625","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0022-510X(91)90193-B","article-title":"Cortical serotonin-S2 receptor binding in Lewy body dementia: alzheimer\u2019s and Parkinson\u2019s diseases","volume":"106","author":"Cheng","year":"1991","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0630","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1017\/S1461145708009218","article-title":"Long-term administration of monoamine oxidase inhibitors alters the firing rate and pattern of dopamine neurons in the ventral tegmental area","volume":"12","author":"Chenu","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0635","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/npp.2012.140","article-title":"Electrophysiological effects of repeated administration of agomelatine on the dopamine norepinephrine, and serotonin systems in the rat brain","volume":"38","author":"Chenu","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0640","article-title":"Role of melatonin, serotonin 2B, and serotonin 2C receptors in modulating the firing activity of rat dopamine neurons","author":"Chenu","year":"2013","journal-title":"J. Psychopharmacol. (Oxf.)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0645","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/289537a0","article-title":"Dendritic release of dopamine in the substantia nigra","volume":"289","author":"Cheramy","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0650","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0166-2236(96)10052-7","article-title":"Basal ganglia and movement disorders: an update","volume":"19","author":"Chesselet","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0655","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0166-2236(90)90109-N","article-title":"Disinhibition as a basic process in the expression of striatal functions","volume":"13","author":"Chevalier","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0660","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.brainres.2004.07.009","article-title":"Clozapine increases both acetylcholine and dopamine release in rat ventral hippocampus: role of 5-HT1A receptor agonism","volume":"1023","author":"Chung","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0665","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/(SICI)1098-2396(199607)23:3<125::AID-SYN1>3.0.CO;2-A","article-title":"Effect of acute and chronic fluoxetine on extracellular dopamine levels in the caudate-putamen and nucleus accumbens of rat","volume":"23","author":"Clark","year":"1996","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0670","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1126\/science.1094987","article-title":"Cognitive inflexibility after prefrontal serotonin depletion","volume":"304","author":"Clarke","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0675","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/cercor\/bhj120","article-title":"Cognitive inflexibility after prefrontal serotonin depletion is behaviorally and neurochemically specific","volume":"17","author":"Clarke","year":"2007","journal-title":"Cerebral Cortex (New York N.Y.: 1991)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0680","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1038\/sj.npp.1300262","article-title":"SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist. I: neurochemical and electrophysiological profile","volume":"28","author":"Claustre","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0685","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0028-3908(99)00086-6","article-title":"Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS","volume":"39","author":"Clemett","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0690","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1111\/j.1460-9568.1996.tb01553.x","article-title":"Lesion study of the distribution of serotonin 5-HT4 receptors in rat basal ganglia and hippocampus","volume":"8","author":"Compan","year":"1996","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0695","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0006-8993(98)00168-1","article-title":"Selective increases in serotonin 5-HT1B\/1D and 5-HT2A\/2C binding sites in adult rat basal ganglia following lesions of serotonergic neurons","volume":"793","author":"Compan","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0700","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1097\/00001756-199406020-00018","article-title":"5-HT4 receptor stimulation facilitates acetylcholine release in rat frontal cortex","volume":"5","author":"Consolo","year":"1994","journal-title":"Neuroreport"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0705","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0361-9230(90)90072-8","article-title":"Afferent and efferent connections of the laterodorsal tegmental nucleus in the rat","volume":"25","author":"Cornwall","year":"1990","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0710","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/sj.npp.1300474","article-title":"Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade","volume":"29","author":"Cremers","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0715","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/sj.npp.1301287","article-title":"Augmentation of SSRI effects on serotonin by 5-HT2C antagonists: mechanistic studies","volume":"32","author":"Cremers","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0720","article-title":"Pimavanserin for patients with Parkinson\u2019s disease psychosis: a randomised, placebo-controlled phase 3 trial","author":"Cummings","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0725","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1001\/archneur.1993.00540080076020","article-title":"Frontal-subcortical circuits and human behavior","volume":"50","author":"Cummings","year":"1993","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0730","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.neuropharm.2011.04.034","article-title":"Selective serotonin 5-HT(2C) receptor activation suppresses the reinforcing efficacy of cocaine and sucrose but differentially affects the incentive-salience value of cocaine- vs. sucrose-associated cues","volume":"61","author":"Cunningham","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0735","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0022-3565(25)39080-4","article-title":"Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine","volume":"242","author":"D\u2019Amato","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0740","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0014-2999(00)00566-5","article-title":"The role of dopamine in the mechanism of action of antidepressant drugs","volume":"405","author":"D\u2019Aquila","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0745","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.neuron.2011.01.020","article-title":"Impulsivity compulsivity, and top-down cognitive control","volume":"69","author":"Dalley","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0750","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.neuropharm.2003.11.012","article-title":"mCPP-induced hyperactivity in 5-HT2C receptor mutant mice is mediated by activation of multiple 5-HT receptor subtypes","volume":"46","author":"Dalton","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0755","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/16941","article-title":"The 5-HT3B subunit is a major determinant of serotonin-receptor function","volume":"397","author":"Davies","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0760","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.coph.2011.01.010","article-title":"Allosteric modulation of the 5-HT(3) receptor","volume":"11","author":"Davies","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0765","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1176\/ajp.148.11.1474","article-title":"Dopamine in schizophrenia: a review and reconceptualization","volume":"148","author":"Davis","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0770","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0893-6080(02)00052-7","article-title":"Opponent interactions between serotonin and dopamine","volume":"15","author":"Daw","year":"2002","journal-title":"Neural Netw."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0775","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00702-003-0812-1","article-title":"Effects of 5-HT(6) receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat","volume":"110","author":"Dawson","year":"2003","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0780","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/sj.bjp.0703288","article-title":"In vivo effects of the 5-HT(6) antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline dopamine, 5-HT, glutamate and aspartate","volume":"130","author":"Dawson","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0785","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0893-133X(01)00265-2","article-title":"The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus","volume":"25","author":"Dawson","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0790","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0361-9230(02)00967-X","article-title":"Potentiation of amphetamine-induced changes in dopamine and 5-HT by a 5-HT(6) receptor antagonist","volume":"59","author":"Dawson","year":"2003","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0795","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev.neuro.051508.135607","article-title":"Serotonin in affective control","volume":"32","author":"Dayan","year":"2009","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0800","series-title":"S\u00e9rotonine: Aspects Biologiques Et Cliniques","first-page":"329","article-title":"Aspects physiologiques et physiopathologiques de la transmission s\u00e9rotoninergique au sein des ganglions de la base","author":"De Deurwaerd\u00e8re","year":"2012"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0805","doi-asserted-by":"crossref","DOI":"10.1358\/dot.2016.52.2.2461868","article-title":"Cariprazine: new dopamine biased agonist for neuropsychiatric disorders","author":"De Deurwaerd\u00e8re","year":"2016","journal-title":"Drugs Today"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0810","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1523\/JNEUROSCI.20-13-05170.2000","article-title":"Nigrostriatal lesions alter oral dyskinesia and c-Fos expression induced by the serotonin agonist 1-(m-chlorophenyl) piperazine in adult rats","volume":"20","author":"De Deurwaerdere","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurol.2012.01.585","article-title":"What can we expect from the serotonergic side of l-DOPA?","author":"De Deurwaerdere","year":"2012","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0820","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0165-6147(00)01811-3","article-title":"The nigrostriatal dopamine system: a neglected target for 5-HT2C receptors","volume":"22","author":"De Deurwaerdere","year":"2001","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0825","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1046\/j.1471-4159.1995.65031100.x","article-title":"d-fenfluramine increases striatal extracellular dopamine in vivo independently of serotonergic terminals or dopamine uptake sites","volume":"65","author":"De Deurwaerdere","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0830","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1046\/j.1471-4159.1996.66010210.x","article-title":"Serotonin enhances striatal dopamine outflow in vivo through dopamine uptake sites","volume":"66","author":"De Deurwaerdere","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0835","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1471-4159.1997.68010195.x","article-title":"Serotonin stimulation of 5-HT4 receptors indirectly enhances in vivo dopamine release in the rat striatum","volume":"68","author":"De Deurwaerdere","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0840","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1523\/JNEUROSCI.18-16-06528.1998","article-title":"Opposite change of in vivo dopamine release in the rat nucleus accumbens and striatum that follows electrical stimulation of dorsal raphe nucleus: role of 5-HT3 receptors","volume":"18","author":"De Deurwaerdere","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0845","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0091-3057(01)00703-1","article-title":"Central 5-HT(4) receptors and dopamine-dependent motor behaviors: searching for a functional role","volume":"71","author":"De Deurwaerdere","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0850","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1523\/JNEUROSCI.0112-04.2004","article-title":"Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens","volume":"24","author":"De Deurwaerdere","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0855","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1471-4159.2005.03174.x","article-title":"Regionally and functionally distinct serotonin3 receptors control in vivo dopamine outflow in the rat nucleus accumbens","volume":"94","author":"De Deurwaerdere","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0860","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.neulet.2009.12.006","article-title":"Selective blockade of serotonin 2C receptor enhances Fos expression specifically in the striatum and the subthalamic nucleus within the basal ganglia","volume":"469","author":"De Deurwaerdere","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0865","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00221-013-3508-2","article-title":"Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology","volume":"230","author":"De Deurwaerdere","year":"2013","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0870","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-2999(03)02154-X","article-title":"Role of 5-HT1B receptors in the regulation of extracellular serotonin and dopamine in the dorsal striatum of mice","volume":"476","author":"De Groote","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0875","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0006-8993(87)90683-4","article-title":"Modulation of striatal dopamine metabolism by the activity of dorsal raphe serotonergic afferences","volume":"411","author":"De Simoni","year":"1987","journal-title":"Brain Res."},{"issue":"Suppl (3)","key":"10.1016\/j.pneurobio.2016.03.004_bib0880","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.1016\/S1353-8020(09)70822-3","article-title":"Update on models of basal ganglia function and dysfunction","volume":"15","author":"DeLong","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0885","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00213-008-1177-9","article-title":"S32006: a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models","volume":"199","author":"Dekeyne","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0890","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fnsys.2011.00031","article-title":"Noradrenaline and parkinson\u2019s disease","volume":"5","author":"Delaville","year":"2011","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0895","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.nbd.2011.10.023","article-title":"Emerging dysfunctions consequent to combined monoaminergic depletions in Parkinsonism","volume":"45","author":"Delaville","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0900","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.neuroscience.2011.11.024","article-title":"Effects of noradrenaline and serotonin depletions on the neuronal activity of globus pallidus and substantia nigra pars reticulata in experimental parkinsonism","volume":"202","author":"Delaville","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0905","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuropharm.2013.02.005","article-title":"The two faces of the pharmacological interaction of mGlu2 and 5-HT(2)A ? relevance of receptor heterocomplexes and interaction through functional brain pathways","volume":"70","author":"Delille","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0910","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00213-004-1880-0","article-title":"Synergistic dopamine increase in the rat prefrontal cortex with the combination of quetiapine and fluvoxamine","volume":"176","author":"Denys","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0915","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0079-6123(00)25005-X","article-title":"Ultrastructural evidence for diffuse transmission by monoamine and acetylcholine neurons of the central nervous system","volume":"125","author":"Descarries","year":"2000","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0920","series-title":"Transmission in the Brain: Novel Mechanisms for Neural Transmission","first-page":"53","article-title":"Nonjunctional relationships of monoamine axon terminals in the cerebral cortex of adult rat","author":"Descarries","year":"1991"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0925","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0014-2999(87)90356-6","article-title":"Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response","volume":"134","author":"Deutch","year":"1987","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0930","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0920-9964(91)90030-U","article-title":"Mechanisms of action of atypical antipsychotic drugs: implications for novel therapeutic strategies for schizophrenia","volume":"4","author":"Deutch","year":"1991","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0935","first-page":"61","article-title":"The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia","volume":"36","author":"Deutch","year":"1992","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0940","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF01245232","article-title":"Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson\u2019s disease","volume":"91","author":"Deutch","year":"1993","journal-title":"J. Neural transm. Gen. Sect."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0945","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/j.1471-4159.1992.tb08461.x","article-title":"Alterations in extracellular and tissue levels of biogenic amines in rat brain induced by the serotonin2 receptor antagonist ritanserin","volume":"59","author":"Devaud","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0950","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00221-013-3593-2","article-title":"Serotonin2C receptors and drug addiction: focus on cocaine","volume":"230","author":"Devroye","year":"2013","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0955","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.neuropharm.2014.10.016","article-title":"Serotonin2C receptor stimulation inhibits cocaine-induced Fos expression and DARPP-32 phosphorylation in the rat striatum independently of dopamine outflow","volume":"89","author":"Devroye","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0960","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/syn.890090104","article-title":"[3H]paroxetine binding and serotonin content of rat and rabbit cortical areas hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region","volume":"9","author":"Dewar","year":"1991","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0965","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1523\/JNEUROSCI.15-01-00821.1995","article-title":"Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis","volume":"15","author":"Dewey","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0970","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0975","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0165-6147(92)90135-S","article-title":"Reinforcing drug seeking","volume":"13","author":"Di Chiara","year":"1992","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0980","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0376-8716(95)01118-I","article-title":"The role of dopamine in drug abuse viewed from the perspective of its role in motivation","volume":"38","author":"Di Chiara","year":"1995","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0985","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pharmthera.2015.11.009","article-title":"New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders","volume":"157","author":"Di Giovanni","year":"2016","journal-title":"Rev. Pharmacol. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0990","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0306-4522(98)00655-1","article-title":"Selective blockade of serotonin-2C\/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study","volume":"91","author":"Di Giovanni","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib0995","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1098-2396(200001)35:1<53::AID-SYN7>3.0.CO;2-2","article-title":"Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C\/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study","volume":"35","author":"Di Giovanni","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1000","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0306-4522(00)00561-3","article-title":"m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors","volume":"103","author":"Di Giovanni","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1005","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.2174\/156802606778522113","article-title":"Central serotonin2C receptor: from physiology to pathology","volume":"6","author":"Di Giovanni","year":"2006","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1010","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.2174\/092986706778521805","article-title":"Serotonin involvement in the basal ganglia pathophysiology: could the 5-HT2C receptor be a new target for therapeutic strategies?","volume":"13","author":"Di Giovanni","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1015","doi-asserted-by":"crossref","DOI":"10.1016\/S0079-6123(08)00903-5","article-title":"Serotonin-dopamine interaction: experimental evidence and therapeutic relevance. Preface","volume":"172","author":"Di Giovanni","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1020","author":"Di Giovanni","year":"2008"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1025","doi-asserted-by":"crossref","unstructured":"Di Giovanni, G., Di Matteo, V., Esposito, E., 2009. Birth, life and death of dopaminergic neurons in the substantia nigra.","DOI":"10.1007\/978-3-211-92660-4"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1030","series-title":"The Basal Ganglia IX","first-page":"285","article-title":"Preferential modulation of the GABAergic vs. dopaminergic function in the substantia nigra by 5-HT2C receptor","author":"Di Giovanni","year":"2009"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1035","series-title":"5-HT2C Receptors in the Pathophysiology of CNS Disease","author":"Di Giovanni","year":"2011"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1040","first-page":"957","article-title":"The degree of inhibition of dopaminergic neurons in the ventral tegmental area induced by selective serotonin reuptake inhibitors is a function of the density-power-spectrum of the interspike interval","volume":"79","author":"Di Mascio","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1045","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0306-4522(98)00757-X","article-title":"Decreased chaos of midbrain dopaminergic neurons after serotonin denervation","volume":"92","author":"Di Mascio","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1050","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0028-3908(98)00014-8","article-title":"Selective blockade of serotonin2C\/2B receptors enhances dopamine release in the rat nucleus accumbens","volume":"37","author":"Di Matteo","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1055","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0028-3908(99)00047-7","article-title":"SB 242 084 a selective serotonin(2C) receptor antagonist, increases dopaminergic transmission in the mesolimbic system","volume":"38","author":"Di Matteo","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1060","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0028-3908(99)00047-7","article-title":"SB 242084 a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system","volume":"38","author":"Di Matteo","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1065","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0006-8993(00)02246-0","article-title":"Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin(2C) receptors","volume":"865","author":"Di Matteo","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1070","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0006-8993(00)02246-0","article-title":"Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin(2C) receptors","volume":"865","author":"Di Matteo","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s002130000420","article-title":"Acute administration of amitriptyline and mianserin increases dopamine release in the rat nucleus accumbens: possible involvement of serotonin2C receptors","volume":"150","author":"Di Matteo","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1080","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0165-6147(00)01688-6","article-title":"Role of 5-HT(2C) receptors in the control of central dopamine function","volume":"22","author":"Di Matteo","year":"2001","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1085","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0091-3057(01)00714-6","article-title":"Biochemical evidence that the atypical antipsychotic drugs clozapine and risperidone block 5-HT(2C) receptors in vivo","volume":"71","author":"Di Matteo","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1090","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0091-3057(01)00705-5","article-title":"Role of serotonin(2C) receptors in the control of brain dopaminergic function","volume":"71","author":"Di Matteo","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1095","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1471-4159.2004.02337.x","article-title":"Selective stimulation of serotonin2c receptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration","volume":"89","author":"Di Matteo","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0079-6123(08)00902-3","article-title":"Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies","volume":"172","author":"Di Matteo","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1105","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0079-6123(08)00921-7","article-title":"Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson\u2019s disease and other motor disorders","volume":"172","author":"Di Matteo","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1110","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/mp.2011.159","article-title":"5-HT(2B) receptors are required for serotonin-selective antidepressant actions","volume":"17","author":"Diaz","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1115","doi-asserted-by":"crossref","first-page":"10831","DOI":"10.1523\/JNEUROSCI.2999-05.2005","article-title":"Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action","volume":"1083","author":"Diaz-Mataix","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1120","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.euroneuro.2005.10.003","article-title":"Activation of pyramidal cells in rat medial prefrontal cortex projecting to ventral tegmental area by a 5-HT1A receptor agonist","volume":"16","author":"Diaz-Mataix","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1125","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nn1104","article-title":"Lmx1b is essential for the development of serotonergic neurons","volume":"6","author":"Ding","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1130","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0006-8993(00)02062-X","article-title":"Ultrastructural localization of the serotonin 2A receptor in dopaminergic neurons in the ventral tegmental area","volume":"864","author":"Doherty","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1135","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/cne.1147","article-title":"Targeting of serotonin 1A receptors to dopaminergic neurons within the parabrachial subdivision of the ventral tegmental area in rat brain","volume":"433","author":"Doherty","year":"2001","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1140","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1523\/JNEUROSCI.5723-07.2008","article-title":"Serotonin 5-HT2B receptors are required for 3,4-methylenedioxymethamphetamine-induced hyperlocomotion and 5-HT release in vivo and in vitro","volume":"28","author":"Doly","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1145","doi-asserted-by":"crossref","first-page":"e7952","DOI":"10.1371\/journal.pone.0007952","article-title":"Role of serotonin via 5-HT2B receptors in the reinforcing effects of MDMA in mice","volume":"4","author":"Doly","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1150","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/PL00005058","article-title":"Characterization of human serotonin 1D and 1B receptors using [3H]-GR-125743: a novel radiolabelled serotonin 5HT1D\/1B receptor antagonist","volume":"356","author":"Domenech","year":"1997","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1155","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/mds.10198","article-title":"Depression leading to attempted suicide after bilateral subthalamic nucleus stimulation for Parkinson\u2019s disease","volume":"17","author":"Doshi","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1160","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0306-4522(99)00494-7","article-title":"Immunolabeling of the rat central nervous system with antibodies partially selective of the short form of the 5-HT3 receptor","volume":"95","author":"Doucet","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1165","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1460-9568.2007.05659.x","article-title":"Immunolabelling of the 5-HT 3B receptor subunit in the central and peripheral nervous systems in rodents","volume":"26","author":"Doucet","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1170","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0006-8993(76)90005-6","article-title":"Evidence for the existence of a raphe projection to the substantia nigra in rat","volume":"113","author":"Dray","year":"1976","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1175","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0006-8993(78)91077-6","article-title":"The dorsal and medial raphe projections to the substantia nigra in the rat: electrophysiological: biochemical and behavioural observations","volume":"151","author":"Dray","year":"1978","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1180","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pnpbp.2003.09.030","article-title":"The serotonin-dopamine interaction is critical for fast-onset action of antidepressant treatment: in vivo studies in an animal model of depression","volume":"28","author":"Dremencov","year":"2004","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1185","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/00001756-200408260-00030","article-title":"Dimensional complexity of the neuronal activity in a rat model of depression","volume":"15","author":"Dremencov","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1190","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neuropharm.2004.09.013","article-title":"Hyperfunctionality of serotonin-2C receptor-mediated inhibition of accumbal dopamine release in an animal model of depression is reversed by antidepressant treatment","volume":"48","author":"Dremencov","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1195","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/138945006775515491","article-title":"Modulation of dopamine transmission by 5HT2C and 5HT3 receptors: a role in the antidepressant response","volume":"7","author":"Dremencov","year":"2006","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1200","first-page":"223","article-title":"Effects of sustained serotonin reuptake inhibition on the firing of dopamine neurons in the rat ventral tegmental area","volume":"34","author":"Dremencov","year":"2009","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1205","series-title":"5-HT2C Receptors in the Pathophysiology of CNS Disease","first-page":"249","article-title":"The role of 5-HT2C receptors in the pathophysiology and treatment of depression","author":"Dremencov","year":"2011"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1210","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1074\/jbc.M112.436972","article-title":"Impaired monoamine and organic cation uptake in choroid plexus in mice with targeted disruption of the plasma membrane monoamine transporter (Slc29a4) gene","volume":"288","author":"Duan","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1215","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0306-4522(94)90466-9","article-title":"Continuous in vivo monitoring of evoked dopamine release in the rat nucleus accumbens by amperometry","volume":"62","author":"Dugast","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1220","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.neuron.2007.08.011","article-title":"A silver bullet for the treatment of depression?","volume":"55","author":"Duman","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1225","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0026-895X(25)10130-2","article-title":"A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system","volume":"34","author":"Dumuis","year":"1988","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1230","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1124\/jpet.111.179572","article-title":"Characterization of vabicaserin (SCA-136): a selective 5-hydroxytryptamine 2C receptor agonist","volume":"337","author":"Dunlop","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1235","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1212\/WNL.45.10.1855","article-title":"Levodopa-induced dyskinesias are improved by fluoxetine","volume":"45","author":"Durif","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1240","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0306-4522(96)00480-0","article-title":"Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system","volume":"76","author":"Duxon","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1245","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0031-6997(25)06933-9","article-title":"Pathogenesis prevention, and treatment of neuroleptic-induced movement disorders","volume":"47","author":"Ebadi","year":"1995","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1250","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/(SICI)1096-9861(19970728)384:2<233::AID-CNE5>3.0.CO;2-2","article-title":"Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats","volume":"384","author":"Eberle-Wang","year":"1997","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1255","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/(SICI)1096-9861(19970728)384:2<233::AID-CNE5>3.0.CO;2-2","article-title":"Pattern of expression of the serotonin(2C) receptor messenger RNA in the basal ganglia of adult rats","volume":"384","author":"EberleWang","year":"1997","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1260","doi-asserted-by":"crossref","first-page":"8184","DOI":"10.1038\/srep08184","article-title":"A concurrent excitation and inhibition of dopaminergic subpopulations in response to nicotine","volume":"5","author":"Eddine","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1265","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00213-008-1226-4","article-title":"Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat","volume":"200","author":"Egerton","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1270","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0165-6147(00)89081-1","article-title":"Central 5-Ht4 receptors","volume":"16","author":"Eglen","year":"1995","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1275","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/pr.56.3.1","article-title":"Catecholamine metabolism: a contemporary view with implications for physiology and medicine","volume":"56","author":"Eisenhofer","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1280","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neuropharm.2014.05.024","article-title":"NMDA receptor antagonism potentiates the L-DOPA-induced extracellular dopamine release in the subthalamic nucleus of hemi-parkinson rats","volume":"85","author":"El Arfani","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1285","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0014-2999(91)90414-L","article-title":"The involvement of dopamine D1 and D2 receptors in the effects of the classical neuroleptic haloperidol and the atypical neuroleptic clozapine","volume":"196","author":"Ellenbroek","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00633189","article-title":"Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites","volume":"332","author":"Engel","year":"1986","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1295","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/j.1471-4159.1981.tb00594.x","article-title":"Characterisation of inhibitory 5-hydroxytryptamine receptors that modulate dopamine release in the striatum","volume":"36","author":"Ennis","year":"1981","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1300","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0893-133X(98)00070-0","article-title":"Effects of mCPP on the extracellular concentrations of serotonin and dopamine in rat brain","volume":"20","author":"Eriksson","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1305","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1073\/pnas.90.8.3452","article-title":"Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain","volume":"90","author":"Erlander","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1310","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.neubiorev.2010.06.007","article-title":"Potential mechanisms underlying anxiety and depression in Parkinson\u2019s disease: consequences of l-DOPA treatment","volume":"35","author":"Eskow Jaunarajs","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1315","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.nbd.2007.01.014","article-title":"alpha-Synuclein and its disease-related mutants interact differentially with the microtubule protein tau and associate with the actin cytoskeleton","volume":"26","author":"Esposito","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1320","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.expneurol.2007.02.008","article-title":"Non-steroidal anti-inflammatory drugs in Parkinson\u2019s disease","volume":"205","author":"Esposito","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1325","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1586\/14737175.7.6.677","article-title":"Death in the substantia nigra: a motor tragedy","volume":"7","author":"Esposito","year":"2007","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1330","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.nbd.2015.07.010","article-title":"The combined depletion of monoamines alters the effectiveness of subthalamic deep brain stimulation","volume":"82","author":"Faggiani","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1335","doi-asserted-by":"crossref","first-page":"19S","DOI":"10.1097\/00004714-199502001-00004","article-title":"Positron emission tomography studies on D2 and 5-HT2 receptor binding in risperidone-treated schizophrenic patients","volume":"15","author":"Farde","year":"1995","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1340","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1212\/01.wnl.0000191325.31068.c4","article-title":"Hallucinations in Parkinson disease in the prelevodopa era","volume":"66","author":"Fenelon","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1345","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1476-5381.1986.tb10250.x","article-title":"False labelling of dopaminergic terminals in the rabbit caudate nucleus: uptake and release of [3H]-5-hydroxytryptamine","volume":"88","author":"Feuerstein","year":"1986","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1350","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/0306-4522(77)90120-8","article-title":"Anatomical and electrophysiological investigation of serotonergic projection from dorsal raphe nucleus to substantia nigra in rat","volume":"2","author":"Fibiger","year":"1977","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1355","first-page":"1","article-title":"Neurobiology of depression: focus on dopamine","volume":"49","author":"Fibiger","year":"1995","journal-title":"Adv. Biochem. Psychopharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1360","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2014.02.010","article-title":"Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS monoamine neurotransmitter release","volume":"143","author":"Finberg","year":"2014","journal-title":"Pharmacol. Therapeutics"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1365","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1124\/pr.59.07103","article-title":"5-HT receptor regulation of neurotransmitter release","volume":"59","author":"Fink","year":"2007","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1370","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neuroscience.2013.09.059","article-title":"Monoamines tissue content analysis reveals restricted and site-specific correlations in brain regions involved in cognition","volume":"255","author":"Fitoussi","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1375","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1007\/s00429-014-0868-8","article-title":"Prefronto-subcortical imbalance characterizes poor decision-making: neurochemical and neural functional evidences in rats","volume":"220","author":"Fitoussi","year":"2015","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1380","first-page":"576","article-title":"Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding","volume":"27","author":"Fletcher","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1385","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s00213-002-1104-4","article-title":"Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement","volume":"162","author":"Fletcher","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1390","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.neuropharm.2009.05.011","article-title":"Characterizing the effects of 5-HT(2C) receptor ligands on motor activity and feeding behaviour in 5-HT(2C) receptor knockout mice","volume":"57","author":"Fletcher","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1395","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3940(95)11597-P","article-title":"5-Hydroxytryptamine increases spontaneous activity of subthalamic neurons in the rat","volume":"192","author":"Flores","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1400","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/exnr.1998.6792","article-title":"Behavioral effects of 5-HT2C receptor antagonism in the substantia nigra zona reticulata of the 6-hydroxydopamine-lesioned rat model of Parkinson\u2019s disease","volume":"151","author":"Fox","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1405","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0079-6123(08)00923-0","article-title":"Parkinson's disease\u2013opportunities for novel therapeutics to reduce the problems of levodopa therapy","volume":"172","author":"Fox","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1410","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s40265-013-0105-4","article-title":"Non-dopaminergic treatments for motor control in Parkinson\u2019s disease","volume":"73","author":"Fox","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1415","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00213-010-1982-9","article-title":"Serotonin 5-HT4 receptors in the nucleus accumbens are specifically involved in the appetite suppressant and not locomotor stimulant effects of MDMA (\u2018ecstasy\u2019)","volume":"213","author":"Francis","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1420","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0028-3908(01)00165-4","article-title":"5-HT(6) receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine","volume":"42","author":"Frantz","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1425","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2334\/josnusd.50.387","article-title":"5-HT(1A) and 5-HT(1B) receptors in the ventrolateral striatum differentially modulate apomorphine-induced jaw movements in rats","volume":"50","author":"Fujita","year":"2008","journal-title":"J. Oral Sci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1430","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/syn.890150109","article-title":"Local infusion of the selective 5HT-1b agonist CP-93, 129 facilitates striatal dopamine release in vivo","volume":"15","author":"Galloway","year":"1993","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1435","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.celrep.2015.07.005","article-title":"Depression of serotonin synaptic transmission by the dopamine precursor L-DOPA","volume":"12","author":"Gantz","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1440","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1523\/JNEUROSCI.5347-06.2007","article-title":"Functional coupling between the prefrontal cortex and dopamine neurons in the ventral tegmental area","volume":"27","author":"Gao","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1445","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1098\/rstb.2011.0378","article-title":"Probing the diversity of serotonin neurons","volume":"367","author":"Gaspar","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. Series B. Biol. Sci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1450","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/j.1476-5381.1996.tb15309.x","article-title":"5-HT4 receptor-mediated modulation of 5-HT release in the rat hippocampus in vivo","volume":"117","author":"Ge","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1455","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1515\/REVNEURO.2008.19.4-5.227","article-title":"Functional implications of glutamatergic projections to the ventral tegmental area","volume":"19","author":"Geisler","year":"2008","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1460","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.1523\/JNEUROSCI.0012-07.2007","article-title":"Glutamatergic afferents of the ventral tegmental area in the rat","volume":"27","author":"Geisler","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1465","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1586\/ern.09.51","article-title":"The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's disease","volume":"9","author":"Geldenhuys","year":"2009","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1470","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00221-013-3694-y","article-title":"The serotonin 5-HT7 receptors: two decades of research","volume":"230","author":"Gellynck","year":"2013","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1475","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/(SICI)1098-2396(199809)30:1<71::AID-SYN9>3.0.CO;2-H","article-title":"5-HT3 receptor activation is required for induction of striatal c-Fos and phosphorylation of ATF-1 by amphetamine","volume":"30","author":"Genova","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1480","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/j.1460-2075.1995.tb07280.x","article-title":"The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants","volume":"14","author":"Gerald","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1485","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/(SICI)1098-2396(199607)23:3<164::AID-SYN5>3.0.CO;2-6","article-title":"Quantitative RT-PCR distribution of serotonin 5-HT6 receptor mRNA in the central nervous system of control or 5,7-dihydroxytryptamine-treated rats","volume":"23","author":"Gerard","year":"1996","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1490","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0006-8993(96)01224-3","article-title":"Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system","volume":"746","author":"Gerard","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1495","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/(SICI)1098-2396(20000315)35:4<281::AID-SYN6>3.0.CO;2-A","article-title":"Dorsal raphe stimulation differentially modulates dopaminergic neurons in the ventral tegmental area and substantia nigra","volume":"35","author":"Gervais","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1500","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.euroneuro.2011.11.005","article-title":"Electrophysiological impact of trazodone on the dopamine and norepinephrine systems in the rat brain","volume":"22","author":"Ghanbari","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1505","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0006-8993(78)91110-1","article-title":"Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites","volume":"152","author":"Giambalvo","year":"1978","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2004.01.036","article-title":"Contributions of 5-HT2C receptors to multiple actions of central serotonin systems","volume":"488","author":"Giorgetti","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2004.01.036","article-title":"Contributions of 5-HT(2C) receptors to multiple actions of central serotonin systems","volume":"488","author":"Giorgetti","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1520","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0028-3908(98)00188-9","article-title":"Serotonin (5-HT) 2A receptor activation enhances dialysate levels of dopamine and noradrenaline but not 5-HT, in the frontal cortex of freely-moving rats","volume":"38","author":"Gobert","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1525","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1046\/j.1471-4159.1997.68031159.x","article-title":"Potentiation of the fluoxetine-induced increase in dialysate levels of serotonin (5-HT) in the frontal cortex of freely moving rats by combined blockade of 5-HT1A and 5-HT1B receptors with WAY 100,635 and GR 127,935","volume":"68","author":"Gobert","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1530","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0306-4522(97)00565-4","article-title":"Simultaneous quantification of serotonin: dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal Auto- and heteroreceptor-mediated control of release","volume":"84","author":"Gobert","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1535","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0306-4522(99)00211-0","article-title":"Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine: noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions","volume":"93","author":"Gobert","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1540","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/(SICI)1098-2396(20000601)36:3<205::AID-SYN5>3.0.CO;2-D","article-title":"Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat","volume":"36","author":"Gobert","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1545","doi-asserted-by":"crossref","DOI":"10.1002\/cne.22787","article-title":"Differential projections from the lateral habenula to the rostromedial tegmental nucleus and ventral tegmental area in the rat","volume":"520","author":"Gon\u00e7alves","year":"2012","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1550","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0091-3057(92)90383-Q","article-title":"Supersensitized oral responses to a serotonin agonist in neonatal 6-OHDA-treated rats","volume":"41","author":"Gong","year":"1992","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1555","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0022-3565(25)11111-7","article-title":"Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin system","volume":"261","author":"Gong","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1560","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1046\/j.1471-4159.1994.63041282.x","article-title":"Neonatal 6-hydroxydopamine and adult SKF 38393 treatments alter dopamine D1 receptor mRNA levels: absence of other neurochemical associations with the enhanced behavioral responses of lesioned rats","volume":"63","author":"Gong","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1565","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0306-4522(88)90307-7","article-title":"Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry","volume":"24","author":"Gonon","year":"1988","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1570","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature06612","article-title":"Identification of a serotonin\/glutamate receptor complex implicated in psychosis","volume":"452","author":"Gonzalez-Maeso","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1575","first-page":"477","article-title":"Behavioral effects of l-dopa in man","volume":"3","author":"Goodwin","year":"1971","journal-title":"Semin. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1580","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/305140a0","article-title":"Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT","volume":"305","author":"Gozlan","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1585","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0306-4522(83)90135-5","article-title":"Intracellular and extracellular electrophysiology of nigral dopaminergic neurons\u20131: Identification and characterization","volume":"10","author":"Grace","year":"1983","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1590","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0006-8993(85)91581-1","article-title":"Opposing effects of striatonigral feedback pathways on midbrain dopamine cell activity","volume":"333","author":"Grace","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1595","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/jnnp.63.4.434","article-title":"Hallucinosis in idiopathic Parkinson's disease","volume":"63","author":"Graham","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1600","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00213-008-1433-z","article-title":"WAY-163909 a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics","volume":"204","author":"Grauer","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1605","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.conb.2005.10.006","article-title":"The basal ganglia: learning new tricks and loving it","volume":"15","author":"Graybiel","year":"2005","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1610","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1476-5381.1993.tb13617.x","article-title":"Development of a radioligand binding assay for 5-HT4 receptors in guinea-pig and rat brain","volume":"109","author":"Grossman","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1615","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0022-3565(24)39021-4","article-title":"Studies to investigate the role of 5-HT(2C) receptors on cocaine- and food-maintained behavior","volume":"295","author":"Grottick","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1620","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s002130100801","article-title":"Activation of 5-HT(2C) receptors reduces the locomotor and rewarding effects of nicotine","volume":"157","author":"Grottick","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1625","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0014-2999(94)90669-6","article-title":"Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists","volume":"264","author":"Gudelsky","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1630","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.neuroscience.2010.05.059","article-title":"In vivo modulation of the firing activity of putative slow- and fast-spiking interneurons in the medial prefrontal cortex by 5-HT3 receptors in 6-hydroxydopamine-induced Parkinsonian rats","volume":"169","author":"Gui","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1635","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1017\/S1461145707008383","article-title":"Functional interactions between dopamine: serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions","volume":"11","author":"Guiard","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1640","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00228-007-0450-x","article-title":"Further evidence for the association between 5-HT2C receptor gene polymorphisms and extrapyramidal side effects in male schizophrenic patients","volume":"64","author":"Gunes","year":"2008","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1645","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1615\/CritRevNeurobiol.v11.i4.40","article-title":"The primate substantia nigra and VTA: integrative circuitry and function","volume":"11","author":"Haber","year":"1997","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1650","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0165-6147(97)90612-X","article-title":"Parkinson's disease: prospects for improved drug therapy","volume":"18","author":"Hagan","year":"1997","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1655","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1139\/y02-150","article-title":"Effects of clozapine on the efflux of serotonin and dopamine in the rat brain: the role of 5-HT1A receptors","volume":"80","author":"Hagino","year":"2002","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1660","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.0953-816x.2001.01616.x","article-title":"D2-like dopamine receptor activation excites rat dorsal raphe 5-HT neurons in vitro","volume":"14","author":"Haj-Dahmane","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1665","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00213-010-2089-z","article-title":"Functional topography of midbrain and pontine serotonergic systems: implications for synaptic regulation of serotonergic circuits","volume":"213","author":"Hale","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1670","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0006-8993(96)01131-6","article-title":"Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635","volume":"745","author":"Hall","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1675","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0304-3940(97)00178-X","article-title":"Influence of 5-HT1B\/1D receptors on dopamine release in the guinea pig nucleus accumbens: a microdialysis study","volume":"225","author":"Hallbus","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1680","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1749-6632.1990.tb16877.x","article-title":"The central 5-HT1A receptors: pharmacological, biochemical, functional, and regulatory properties","volume":"600","author":"Hamon","year":"1990","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1685","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbr.2008.03.020","article-title":"Molecular biology of 5-HT receptors","volume":"195","author":"Hannon","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1690","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cne.10420","article-title":"Origin of the dopaminergic innervation of the central extended amygdala and accumbens shell: a combined retrograde tracing and immunohistochemical study in the rat","volume":"454","author":"Hasue","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1695","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1046\/j.1471-4159.1997.68041372.x","article-title":"Four 5-hydroxytryptamine7 (5-HT7) receptor isoforms in human and rat produced by alternative splicing: species differences due to altered intron-exon organization","volume":"68","author":"Heidmann","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1700","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0306-4522(91)90202-Y","article-title":"Specificity in the projection patterns of accumbal core and shell in the rat","volume":"41","author":"Heimer","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1705","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0165-6147(92)90054-A","article-title":"Of mice and flies: commonalities among 5-HT receptors","volume":"13","author":"Hen","year":"1992","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1710","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nn.3048","article-title":"Structural correlates of heterogeneous in vivo activity of midbrain dopaminergic neurons","volume":"15","author":"Henny","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1715","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/B978-0-12-411512-5.00009-9","article-title":"Catecholamine\/Serotonin interactions: systems thinking for brain function and disease","volume":"68","author":"Hensler","year":"2013","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1720","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0022-3565(24)38891-3","article-title":"Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors","volume":"295","author":"Herrick-Davis","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1725","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1124\/mol.114.096636","article-title":"Native serotonin 5-HT2C receptors are expressed as homodimers on the apical surface of choroid plexus epithelial cells","volume":"87","author":"Herrick-Davis","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1730","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00221-013-3622-1","article-title":"Functional significance of serotonin receptor dimerization","volume":"230","author":"Herrick-Davis","year":"2013","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1735","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/PL00005259","article-title":"In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei","volume":"358","author":"Hervas","year":"1998","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1740","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0006-8993(87)91588-5","article-title":"Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons","volume":"435","author":"Herve","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1745","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejphar.2003.08.102","article-title":"Serotonin and drug reward: focus on 5-HT2C receptors","volume":"480","author":"Higgins","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1750","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1021\/acschemneuro.5b00025","article-title":"Therapeutic potential of 5-HT2C receptor agonists for addictive disorders","volume":"6","author":"Higgins","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1755","doi-asserted-by":"crossref","first-page":"e00084","DOI":"10.1002\/prp2.84","article-title":"Characterization of the 5-HT2C receptor agonist lorcaserin on efficacy and safety measures in a rat model of diet-induced obesity","volume":"3","author":"Higgins","year":"2015","journal-title":"Pharm. Res. Perspect."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1760","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/cne.22237","article-title":"Vesicular glutamate transporter 3-expressing nonserotonergic projection neurons constitute a subregion in the rat midbrain raphe nuclei","volume":"518","author":"Hioki","year":"2010","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1765","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0169-328X(98)00206-X","article-title":"Cultured astrocytes express messenger RNA for multiple serotonin receptor subtypes: without functional coupling of 5-HT1 receptor subtypes to adenylyl cyclase","volume":"61","author":"Hirst","year":"1998","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1770","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/285476a0","article-title":"Evidence for coexistence of dopamine and CCK in meso-limbic neurones","volume":"285","author":"Hokfelt","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1775","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-3565(25)31520-X","article-title":"Role of monoamine neural systems in L-dihydroxyphenylalanine-stimulated activity","volume":"208","author":"Hollister","year":"1979","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1780","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1046\/j.1471-4159.1995.65020770.x","article-title":"Selective increase in dopamine utilization in the shell subdivision of the nucleus accumbens by the benzodiazepine inverse agonist FG 7142","volume":"65","author":"Horger","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1785","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pnpbp.2012.08.005","article-title":"Binding of lurasidone a novel antipsychotic, to rat 5-HT7 receptor: analysis by [3H]SB-269970 autoradiography","volume":"40","author":"Horisawa","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1790","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/jnnp.72.6.701","article-title":"Behavioural disorders, Parkinson's disease and subthalamic stimulation","volume":"72","author":"Houeto","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1795","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.pbb.2010.10.003","article-title":"Combination of escitalopram and a 5-HT((1)A) receptor antagonist selectively decreases the extracellular levels of dopamine in the nucleus accumbens relative to striatum through 5-HT((2)C) receptor stimulation; suggestive of antipsychotic potential","volume":"97","author":"Hovelso","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1800","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1124\/pr.114.009514","article-title":"Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder","volume":"67","author":"Howell","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1805","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The dopamine hypothesis of schizophrenia: version III\u2014the final common pathway","volume":"35","author":"Howes","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1810","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0031-6997(25)06783-3","article-title":"International union of pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin)","volume":"46","author":"Hoyer","year":"1994","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1815","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","article-title":"Molecular, pharmacological and functional diversity of 5-HT receptors","volume":"71","author":"Hoyer","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1820","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0022-3565(25)13363-6","article-title":"Antidepressant binding sites in brain: autoradiographic comparison of [3H]paroxetine and [3H]imipramine localization and relationship to serotonin transporter","volume":"252","author":"Hrdina","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1825","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bbr.2006.03.040","article-title":"Olanzapine differentially affects 5-HT2Aand2C receptor mRNA expression in the rat brain","volume":"171","author":"Huang","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1830","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/WNR.0b013e328352de40","article-title":"5-HT1A and 5-HT7 receptors contribute to lurasidone-induced dopamine efflux","volume":"23","author":"Huang","year":"2012","journal-title":"Neuroreport"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1835","article-title":"Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT) and DA D antagonism and 5-HT partial agonism","author":"Huang","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1840","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/pr.111.005678","article-title":"The pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease","volume":"65","author":"Huot","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1845","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/S0028-3908(00)00089-7","article-title":"Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C\/2B) receptor antagonists: neurochemical and behavioural studies","volume":"39","author":"Hutson","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1850","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0006-8993(95)00865-N","article-title":"DOI a 5-HT2A\/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum","volume":"698","author":"Ichikawa","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1855","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0014-2999(95)00264-L","article-title":"Effect of antidepressants on striatal and accumbens extracellular dopamine levels","volume":"281","author":"Ichikawa","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1860","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0006-8993(99)01876-4","article-title":"The effect of ipsapirone and S(?)-pindolol on dopamine release in rat striatum and nucleus accumbens","volume":"842","author":"Ichikawa","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1865","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0022-3565(24)35231-0","article-title":"R(+)-8-OH-DPAT a serotonin(1A) receptor agonist, potentiated S(?)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum","volume":"291","author":"Ichikawa","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1870","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(99)00517-8","article-title":"Valproate and carbamazepine increase prefrontal dopamine release by 5-HT1A receptor activation","volume":"380","author":"Ichikawa","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1875","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0006-8993(99)02346-X","article-title":"The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens","volume":"858","author":"Ichikawa","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1880","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0014-2999(95)00624-9","article-title":"R(+)-8-OH-DPAT a 5-HT1A receptor agonist, inhibits amphetamine-induced dopamine release in rat striatum and nucleus accumbens","volume":"287","author":"Ichikawa","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1885","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0006-8993(01)02596-3","article-title":"DOI a 5-HT2A\/2C receptor agonist, attenuates clozapine-induced cortical dopamine release","volume":"907","author":"Ichikawa","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1890","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1046\/j.1471-4159.2001.00154.x","article-title":"5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release","volume":"76","author":"Ichikawa","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1895","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0006-8993(02)03570-9","article-title":"Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone: preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism","volume":"956","author":"Ichikawa","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1900","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.brainres.2005.06.009","article-title":"Valproic acid potentiates both typical and atypical antipsychotic-induced prefrontal cortical dopamine release","volume":"1052","author":"Ichikawa","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1905","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF02190411","article-title":"Mianserin treatment of patients with psychosis induced by antiparkinsonian drugs","volume":"244","author":"Ikeguchi","year":"1995","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1910","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brainresrev.2007.05.004","article-title":"Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex","volume":"56","author":"Ikemoto","year":"2007","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1915","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neubiorev.2010.02.001","article-title":"Brain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theory","volume":"35","author":"Ikemoto","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1920","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0304-3940(89)90533-8","article-title":"5-HT3 receptors control dopamine release in the nucleus accumbens of freely moving rats","volume":"101","author":"Imperato","year":"1989","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1925","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1523\/JNEUROSCI.4388-12.2013","article-title":"Neurons in monkey dorsal raphe nucleus code beginning and progress of step-by-step schedule reward expectation, and amount of reward outcome in the reward schedule task","volume":"33","author":"Inaba","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1930","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0028-3908(88)90134-7","article-title":"8-Hydroxy-2-(di-n-propylamino) tetralin a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis","volume":"27","author":"Invernizzi","year":"1988","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1935","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.bjp.0705341","article-title":"Flibanserin a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate: role of 5-HT(1A) receptors","volume":"139","author":"Invernizzi","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1940","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.neuroscience.2006.11.004","article-title":"Selective activation of 5-HT(2C) receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: a combined in vivo electrophysiological and neurochemical study","volume":"144","author":"Invernizzi","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1945","series-title":"Encyclopedia of Psychopharmacology","first-page":"1","article-title":"Microiontophoresis and related methods","author":"Invernizzi","year":"2014"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1950","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/jnnp.64.4.533","article-title":"Auditory hallucinations in Parkinson\u2019s disease","volume":"64","author":"Inzelberg","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1955","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0022-3565(25)12836-X","article-title":"Serotonin-mediated increase in prefrontal cortex dopamine release: pharmacological characterization","volume":"277","author":"Iyer","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1960","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0028-3908(97)00062-2","article-title":"Identification of 5-HT receptor sub-types in a homogeneous population of presumptive serotoninergic neurones","volume":"36","author":"Jackson","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1965","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1152\/physrev.1992.72.1.165","article-title":"Structure and function of the brain serotonin system","volume":"72","author":"Jacobs","year":"1992","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1970","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0028-3908(94)90162-7","article-title":"Quantitative autoradiography of 5-HT4 receptors in brains of three species using two structurally distinct radioligands, [3H]GR113808 and [3H]BIMU-1","volume":"33","author":"Jakeman","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1975","doi-asserted-by":"crossref","first-page":"16335","DOI":"10.1073\/pnas.0701471104","article-title":"Anorexia induced by activation of serotonin 5-HT4 receptors is mediated by increases in CART in the nucleus accumbens","volume":"104","author":"Jean","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1980","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1038\/tp.2012.131","article-title":"The nucleus accumbens 5-HTR(4)-CART pathway ties anorexia to hyperactivity","volume":"2","author":"Jean","year":"2012","journal-title":"Translat. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1985","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0014-2999(93)90453-O","article-title":"Evidence for a role of 5-HT1C receptors in the antiserotonergic properties of some antidepressant drugs","volume":"231","author":"Jenck","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1990","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0278-5846(94)90013-2","article-title":"Brain 5-HT1C receptors and antidepressants","volume":"18","author":"Jenck","year":"1994","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib1995","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1517\/13543784.7.10.1587","article-title":"The role of 5-HT2C receptors in affective disorders","volume":"7","author":"Jenck","year":"1998","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"Suppl. (2)","key":"10.1016\/j.pneurobio.2016.03.004_bib2000","doi-asserted-by":"crossref","first-page":"277S","DOI":"10.1111\/j.1365-2125.1983.tb05876.x","article-title":"Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson\u2019s disease","volume":"15","author":"Jenner","year":"1983","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2005","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.neuron.2009.02.001","article-title":"The rostromedial tegmental nucleus (RMTg) a GABAergic afferent to midbrain dopamine neurons, encodes aversive stimuli and inhibits motor responses","volume":"61","author":"Jhou","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2010","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/cne.21891","article-title":"The mesopontine rostromedial tegmental nucleus: a structure targeted by the lateral habenula that projects to the ventral tegmental area of Tsai and substantia nigra compacta","volume":"513","author":"Jhou","year":"2009","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2015","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nm1349","article-title":"Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse","volume":"12","author":"Ji","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2020","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0006-8993(90)91103-N","article-title":"The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study","volume":"513","author":"Jiang","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2025","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1523\/JNEUROSCI.12-05-02000.1992","article-title":"5-hydroxytryptamine1B receptors block the GABAB synaptic potential in rat dopamine neurons","volume":"12","author":"Johnson","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0022-3565(25)38294-7","article-title":"Serotonin 5-HT1A receptors mediate inhibition of tyrosine hydroxylation in rat striatum","volume":"266","author":"Johnson","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2035","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0166-4328(96)00123-4","article-title":"The anxiolytic serotonin 5-HT1A receptor agonists buspirone: ipsapirone and gepirone are inhibitors of tyrosine hydroxylation in rat striatum","volume":"73","author":"Johnson","year":"1996","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2040","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0091-3057(01)00745-6","article-title":"The medical benefit of 5-HT research","volume":"71","author":"Jones","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2045","doi-asserted-by":"crossref","first-page":"9780","DOI":"10.1523\/JNEUROSCI.19-22-09780.1999","article-title":"Amphetamine depresses excitatory synaptic transmission via serotonin receptors in the ventral tegmental area","volume":"19","author":"Jones","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2050","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0165-0270(93)90097-B","article-title":"Quantitative microdialysis of neurotransmitters","volume":"48","author":"Justice","year":"1993","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2012.05.022","article-title":"Diverse effects of 5-HT2C receptor blocking agents on c-Fos expression in the rat basal ganglia","volume":"689","author":"Kadiri","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2060","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0165-0173(93)90008-N","article-title":"Neurotransmitter regulation of dopamine neurons in the ventral tegmental area","volume":"18","author":"Kalivas","year":"1993","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2065","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0022-3565(25)22107-3","article-title":"Amphetamine inhibits the electrically evoked release of [3H]dopamine from slices of the rabbit caudate","volume":"227","author":"Kamal","year":"1983","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2070","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1600-0773.1996.tb01382.x","article-title":"5-HT3 receptor antagonist MDL 72222 Dose-dependently attenuates cocaine- and amphetamine-induced elevations of extracellular dopamine in the nucleus accumbens and the dorsal striatum","volume":"78","author":"Kankaanpaa","year":"1996","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2075","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00213-001-0939-4","article-title":"5-HT3 receptor antagonist MDL 72222 attenuates cocaine- and mazindol-: but not methylphenidate-induced neurochemical and behavioral effects in the rat","volume":"159","author":"Kankaanpaa","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2080","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1471-4159.2000.0740263.x","article-title":"Reserpine pretreatment prevents increases in extracellular striatal dopamine following L-DOPA administration in rats with nigrostriatal denervation","volume":"74","author":"Kannari","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2085","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1046\/j.1471-4159.2001.00184.x","article-title":"Activation of 5-HT(1A) but not 5-HT(1B) receptors attenuates an increase in extracellular dopamine derived from exogenously administered L-DOPA in the striatum with nigrostriatal denervation","volume":"76","author":"Kannari","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2090","first-page":"133","article-title":"Tandospirone citrate a selective 5-HT1A agonist, alleviates L-DOPA-induced dyskinesia in patients with Parkinson\u2019s disease","volume":"54","author":"Kannari","year":"2002","journal-title":"No To Shinkei"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2095","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1176\/ajp.153.4.466","article-title":"Serotonin-dopamine interaction and its relevance to schizophrenia","volume":"153","author":"Kapur","year":"1996","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2100","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev.med.52.1.503","article-title":"Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia","volume":"52","author":"Kapur","year":"2001","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/15622970902717024","article-title":"Beyond the monoaminergic hypothesis: agomelatine: a new antidepressant with an innovative mechanism of action","volume":"10","author":"Kasper","year":"2009","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2110","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/cne.21983","article-title":"Afferents to the GABAergic tail of the ventral tegmental area in the rat","volume":"513","author":"Kaufling","year":"2009","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2115","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1111\/j.1476-5381.2010.00984.x","article-title":"Pharmacological recruitment of the GABAergic tail of the ventral tegmental area by acute drug exposure","volume":"161","author":"Kaufling","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2120","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0893-133X(95)00160-F","article-title":"Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats","volume":"15","author":"Kehne","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0014-2999(89)90812-1","article-title":"(+\/\u2212)-3, 4-Methylenedioxymethamphetamine-induced changes in the basal activity and pharmacological responsiveness of nigrostriatal dopamine neurons","volume":"169","author":"Kelland","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2130","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0022-3565(25)13049-8","article-title":"Serotonergic afferent regulation of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons","volume":"253","author":"Kelland","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2135","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0361-9230(93)90121-Q","article-title":"Ascending afferent regulation of rat midbrain dopamine neurons","volume":"31","author":"Kelland","year":"1993","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2140","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1471-4159.1985.tb05485.x","article-title":"Evidence that [3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro","volume":"45","author":"Kelly","year":"1985","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2145","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1111\/j.1476-5381.1991.tb12369.x","article-title":"Potencies of antagonists indicate that 5-HT1C receptors mediate 1-3(chlorophenyl) piperazine-induced hypophagia","volume":"103","author":"Kennett","year":"1991","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2150","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1476-5381.1996.tb15208.x","article-title":"In vitro and in vivo profile of SB 206553: a potent 5-HT2C\/5-HT2B receptor antagonist with anxiolytic-like properties","volume":"117","author":"Kennett","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2155","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0028-3908(97)00038-5","article-title":"SB 242084: a selective and brain penetrant 5-HT2C receptor antagonist","volume":"36","author":"Kennett","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2160","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0006-8993(93)91674-H","article-title":"5-HT3 receptors in the rat central nervous system are mainly located on nerve fibres and terminals","volume":"612","author":"Kidd","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0166-4328(96)00063-0","article-title":"5-HT3 and 5-HT4 receptors in terminal regions of the mesolimbic system","volume":"73","author":"Kilpatrick","year":"1996","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2170","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/syn.890200202","article-title":"Effect of destruction of serotonin neurons on basal and fenfluramine-induced serotonin release in striatum","volume":"20","author":"Kirby","year":"1995","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2175","first-page":"120","article-title":"Preferential loss of serotonin markers in caudate versus putamen in Parkinson\u2019s disease","volume":"131","author":"Kish","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2180","first-page":"39","article-title":"Biochemistry of Parkinson\u2019s disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson\u2019s disease?","volume":"91","author":"Kish","year":"2003","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2185","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1523\/JNEUROSCI.4080-10.2011","article-title":"A genetically defined morphologically and functionally unique subset of 5-HT neurons in the mouse raphe nuclei","volume":"31","author":"Kiyasova","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2190","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0149-7634(95)00029-1","article-title":"Functional significance of mesolimbic dopamine","volume":"19","author":"Kiyatkin","year":"1995","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2195","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/j.1476-5381.2012.01868.x","article-title":"Distribution of 5-ht(1E) receptors in the mammalian brain and cerebral vasculature: an immunohistochemical and pharmacological study","volume":"166","author":"Klein","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2200","doi-asserted-by":"crossref","first-page":"13715","DOI":"10.1038\/srep13715","article-title":"Monoamine content during the reproductive cycle of Perna perna depends on site of origin on the Atlantic Coast of Morocco","volume":"5","author":"Klouche","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2205","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0022-3565(24)35396-0","article-title":"Regulation of extracellular concentrations of 5-hydroxytryptamine (5-HT) in mouse striatum by 5-HT(1A) and 5-HT(1B) receptors","volume":"292","author":"Knobelman","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2210","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF01273176","article-title":"MDMA induced dopamine release in vivo: role of endogenous serotonin","volume":"104","author":"Koch","year":"1997","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2215","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.neuropharm.2003.09.001","article-title":"Brain region and Dose effects of an olanzapine\/fluoxetine combination on extracellular monoamine concentrations in the rat","volume":"46","author":"Koch","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2220","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1098\/rstb.2008.0094","article-title":"Review. Neurobiological mechanisms for opponent motivational processes in addiction","volume":"363","author":"Koob","year":"2008","journal-title":"Philos. Trans. R. Soc. Lond. Series B Biol. Sci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2225","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.neuropharm.2013.05.024","article-title":"Addiction as a stress surfeit disorder","volume":"76 Pt B","author":"Koob","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2230","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0165-6147(92)90060-J","article-title":"Drugs of abuse: anatomy: pharmacology and function of reward pathways","volume":"13","author":"Koob","year":"1992","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2235","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF03033481","article-title":"Modeling tardive dyskinesia: predictive 5-HT2C receptor antagonist treatment","volume":"11","author":"Kostrzewa","year":"2007","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2240","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0306-4522(93)90157-B","article-title":"The presence of a serotonin uptake inhibitor alters pharmacological manipulations of serotonin release","volume":"52","author":"Kreiss","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2245","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s002100000369","article-title":"The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution","volume":"363","author":"Krobert","year":"2001","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2250","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1212\/WNL.59.9.1421","article-title":"Mania following deep brain stimulation for Parkinson\u2019s disease","volume":"59","author":"Kulisevsky","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2255","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/(SICI)1098-2396(199612)24:4<313::AID-SYN1>3.0.CO;2-G","article-title":"The characterization of the effect of locally applied N-methylquipazine a 5-HT3 receptor agonist, on extracellular dopamine levels in the anterior medial prefrontal cortex in the rat: an in vivo microdialysis study","volume":"24","author":"Kurata","year":"1996","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2260","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0278-5846(99)00065-2","article-title":"Effects of the serotonin2A\/2C receptor agonist and antagonist on phencyclidine-induced dopamine release in rat medial prefrontal cortex","volume":"23","author":"Kuroki","year":"1999","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2265","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0022-3565(24)38019-X","article-title":"Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens","volume":"288","author":"Kuroki","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2270","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0006-8993(03)02516-2","article-title":"5-HT 2A receptor stimulation by DOI a 5-HT 2A\/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens","volume":"972","author":"Kuroki","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2275","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0026-895X(25)09676-2","article-title":"Molecular cloning functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor","volume":"46","author":"Kursar","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2280","doi-asserted-by":"crossref","first-page":"7821","DOI":"10.1523\/JNEUROSCI.1790-05.2005","article-title":"5-HT7 receptor is coupled to G alpha subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology","volume":"25","author":"Kvachnina","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2285","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/syn.10288","article-title":"5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex","volume":"51","author":"Lacroix","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2290","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2174\/1570159X11311020003","article-title":"Serotonin2C receptors and the motor control of oral activity","volume":"11","author":"Lagiere","year":"2013","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2295","doi-asserted-by":"crossref","DOI":"10.1007\/s00221-013-3478-4","article-title":"The enhanced oral response to the 5-HT agonist Ro 60-0175 in parkinsonian rats involves the entopeduncular nucleus: electrophysiological correlates","author":"Lagiere","year":"2013","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2300","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.neuron.2008.01.022","article-title":"Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system","volume":"57","author":"Lammel","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2305","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.neuron.2011.03.025","article-title":"Projection-specific modulation of dopamine neuron synapses by aversive and rewarding stimuli","volume":"70","author":"Lammel","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2310","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nature11527","article-title":"Input-specific control of reward and aversion in the ventral tegmental area","volume":"491","author":"Lammel","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2315","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.neuropharm.2013.03.019","article-title":"Reward and aversion in a heterogeneous midbrain dopamine system","author":"Lammel","year":"2014","journal-title":"Neuropharmacology 76 Pt B"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2320","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/syn.890100402","article-title":"Quantitative autoradiographic mapping of 5-Ht3 receptors in the rat cns using [I-125] iodo-Zacopride and [H-3] zacopride as radioligands","volume":"10","author":"Laporte","year":"1992","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2325","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0014-2999(94)90812-5","article-title":"Selective in vivo labelling of brain 5-HT1A receptors by [3H]WAY 100635 in the mouse","volume":"271","author":"Laporte","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2330","doi-asserted-by":"crossref","first-page":"6605","DOI":"10.1523\/JNEUROSCI.0576-11.2011","article-title":"Dopamine transport by the serotonin transporter: a mechanistically distinct mode of substrate translocation","volume":"31","author":"Larsen","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2335","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1096\/fj.06-5724com","article-title":"Serotonin transport and serotonin transporter-mediated antidepressant recognition are controlled by 5-HT2B receptor signaling in serotonergic neuronal cells","volume":"20","author":"Launay","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2340","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1152\/physrev.1991.71.1.155","article-title":"Mesocorticolimbic dopaminergic network: functional and regulatory roles","volume":"71","author":"Le Moal","year":"1991","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2345","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/npp.2010.190","article-title":"Effects of drugs of abuse on putative rostromedial tegmental neurons: inhibitory afferents to midbrain dopamine cells","volume":"36","author":"Lecca","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2350","doi-asserted-by":"crossref","DOI":"10.1038\/npp.2011.302","article-title":"Inhibitory inputs from rostromedial tegmental neurons regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse","author":"Lecca","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2355","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.neuropharm.2008.10.005","article-title":"Serotonin2C receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbens","volume":"56","author":"Leggio","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2360","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1471-4159.2009.06356.x","article-title":"In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist","volume":"111","author":"Leggio","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2365","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/(SICI)1098-2396(199810)30:2<172::AID-SYN7>3.0.CO;2-9","article-title":"Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)(1A) receptors: wAY 100,635-reversible actions of the highly selective ligands flesinoxan and S 15535","volume":"30","author":"Lejeune","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2370","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0166-2236(93)90010-J","article-title":"Carrier-mediated release of neurotransmitters","volume":"16","author":"Levi","year":"1993","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2375","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0026-895X(25)12558-3","article-title":"Receptor-binding properties in vitro and in vivo of ritanserin: a very potent and long acting serotonin-S2 antagonist","volume":"27","author":"Leysen","year":"1985","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2380","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1568007043482598","article-title":"5-HT2 receptors","volume":"3","author":"Leysen","year":"2004","journal-title":"Curr. drug Targets. CNS neurol. Disord."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2385","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00213-003-1418-x","article-title":"A comparison of the effects of loxapine with ziprasidone and thioridazine on the release of dopamine and acetylcholine in the prefrontal cortex and nucleus accumbens","volume":"167","author":"Li","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2390","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2004.04.028","article-title":"Aripiprazole a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain","volume":"493","author":"Li","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2395","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00213-005-0170-9","article-title":"ACP-103 a 5-HT2A\/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens","volume":"183","author":"Li","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2400","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.brainres.2006.11.060","article-title":"5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus","volume":"1134","author":"Li","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2405","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.1523\/JNEUROSCI.5679-12.2013","article-title":"Association with reward negatively modulates short latency phasic conditioned responses of dorsal raphe nucleus neurons in freely moving rats","volume":"33","author":"Li","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2410","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-8993(02)02620-3","article-title":"5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a Dose-dependent manner","volume":"947","author":"Liegeois","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2415","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.1471-4159.2009.06556.x","article-title":"L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson\u2019s disease: temporal and quantitative relationship to the expression of dyskinesia","volume":"112","author":"Lindgren","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2420","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1152\/jn.00281.2003","article-title":"Serotonin reduces the hyperpolarization-activated current (Ih) in ventral tegmental area dopamine neurons: involvement of 5-HT2 receptors and protein kinase C","volume":"90","author":"Liu","year":"2003","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2425","first-page":"e111","article-title":"Prediction of efficacy of vabicaserin, a 5-HT2C agonist, for the treatment of schizophrenia using a quantitative systems pharmacology model","volume":"3","author":"Liu","year":"2014","journal-title":"CPT: Pharmacometr. Syst. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2430","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.neuron.2014.02.010","article-title":"Dorsal raphe neurons signal reward through 5-HT and glutamate","volume":"81","author":"Liu","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2435","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/cercor\/bhr220","article-title":"5-HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneurons","volume":"22","author":"Llado-Pelfort","year":"2012","journal-title":"Cerebral Cortex (New York N.Y.: 1991)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2440","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00004850-200209000-00004","article-title":"Determination of the Dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist: in the treatment of major depressive disorder: a placebo-controlled Dose range study","volume":"17","author":"Loo","year":"2002","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2445","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/PL00005075","article-title":"Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100, 907","volume":"356","author":"Lopez-Gimenez","year":"1997","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2450","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1196\/annals.1410.004","article-title":"Serotonergic systems anxiety, and affective disorder: focus on the dorsomedial part of the dorsal raphe nucleus","volume":"1148","author":"Lowry","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2455","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/ar.21222","article-title":"Coexpression of serotonin and nitric oxide in the raphe complex: cortical versus subcortical circuit","volume":"293","author":"Lu","year":"2010","journal-title":"Anat. Rec. (Hoboken)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2460","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1046\/j.1460-9568.2002.02150.x","article-title":"5-HT4 receptors exert a frequency-related facilitatory control on dorsal raphe nucleus 5-HT neuronal activity","volume":"16","author":"Lucas","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2465","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1046\/j.1471-4159.2000.740693.x","article-title":"Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum","volume":"74","author":"Lucas","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2470","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s002130050265","article-title":"8-OH-DPAT, a 5-HT1A agonist and ritanserin a 5-HT2A\/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release","volume":"131","author":"Lucas","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2475","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1124\/mol.51.5.755","article-title":"5-Hydroxytryptamine1B receptors modulate the effect of cocaine on c-fos expression: converging evidence using 5-hydroxytryptamine1B knockout mice and the 5-hydroxytryptamine1B\/1D antagonist GR127935","volume":"51","author":"Lucas","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2480","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0028-3908(99)00193-8","article-title":"The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol Dose used","volume":"39","author":"Lucas","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2485","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/S0028-3908(00)00020-4","article-title":"Endogenous serotonin enhances the release of dopamine in the striatum only when nigro-striatal dopaminergic transmission is activated","volume":"39","author":"Lucas","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2490","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.0953-816x.2000.01453.x","article-title":"Neurochemical and electrophysiological evidence that 5-HT4 receptors exert a state-dependent facilitatory control in vivo on nigrostriatal but not mesoaccumbal, dopaminergic function","volume":"13","author":"Lucas","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2495","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.0953-816x.2000.01453.x","article-title":"Neurochemical and electrophysiological evidence that 5-HT4 receptors exert a state-dependent facilitatory control in vivo on nigrostriatal but not mesoaccumbal, dopaminergic function","volume":"13","author":"Lucas","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2500","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.biopsych.2004.12.023","article-title":"Frontocortical 5-HT4 receptors exert positive feedback on serotonergic activity: viral transfections: subacute and chronic treatments with 5-HT4 agonists","volume":"57","author":"Lucas","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2505","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.neuron.2007.07.041","article-title":"Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action","volume":"55","author":"Lucas","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2510","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1101\/lm.037317.114","article-title":"Reward processing by the dorsal raphe nucleus: 5-HT and beyond","volume":"22","author":"Luo","year":"2015","journal-title":"Learning Memory (Cold Spring Harbor, N.Y.)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2515","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0006-8993(98)01248-7","article-title":"Loss of regulation by presynaptic dopamine D2 receptors of exogenous L-DOPA-derived dopamine release in the dopaminergic denervated striatum","volume":"817","author":"Maeda","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2520","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF01244819","article-title":"Effects of sertraline and citalopram given repeatedly on the responsiveness of 5-HT receptor subpopulations","volume":"88","author":"Maj","year":"1992","journal-title":"J. Neural Trans. Gen. Sect."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2525","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/syn.21510","article-title":"Augmentation by escitalopram but not citalopram or R-citalopram, of the effects of low-dose risperidone: behavioral, biochemical, and electrophysiological evidence","volume":"66","author":"Marcus","year":"2012","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2530","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1073\/pnas.0511159103","article-title":"kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex","volume":"103","author":"Margolis","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2535","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1113\/jphysiol.2006.117069","article-title":"The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons?","volume":"577","author":"Margolis","year":"2006","journal-title":"J. Physiol.-Lond."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2540","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1124\/jpet.106.106989","article-title":"WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity","volume":"320","author":"Marquis","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2545","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0091-3057(01)00713-4","article-title":"Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety","volume":"71","author":"Martin","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2550","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.neubiorev.2014.03.001","article-title":"Controversies on the role of 5-HT(2C) receptors in the mechanisms of action of antidepressant drugs","volume":"42","author":"Martin","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2555","first-page":"18","article-title":"5-HT2C receptor desensitization moderates anxiety in 5-HTT deficient mice: from behavioral to cellular evidence","author":"Martin","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2560","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nature08028","article-title":"Two types of dopamine neuron distinctly convey positive and negative motivational signals","volume":"459","author":"Matsumoto","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2565","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(99)00636-6","article-title":"Characterization of endogenous serotonin-mediated regulation of dopamine release in the rat prefrontal cortex","volume":"383","author":"Matsumoto","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2570","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0026-895X(25)13615-8","article-title":"Mouse 5-hydroxytryptamine5A and 5-hydroxytryptamine5B receptors define a new family of serotonin receptors: cloning functional expression, and chromosomal localization","volume":"43","author":"Matthes","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2575","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1016\/0014-2999(95)00333-G","article-title":"Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors","volume":"280","author":"Maurel-Remy","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2580","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0893-133X(98)00087-6","article-title":"Effects of the 5-HT2C\/2B antagonist SB 206553 on hyperactivity induced by cocaine","volume":"20","author":"McCreary","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2585","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/sj.npp.1301098","article-title":"SLV313 (1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-4- [5-(4-fluoro-phenyl)-pyridin-3-ylmethyl]-piperazine monohydrochloride): a novel dopamine D2 receptor antagonist and 5-HT1A receptor agonist potential antipsychotic drug","volume":"32","author":"McCreary","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2590","series-title":"Neuroscience Meeting Planner","first-page":"2012","article-title":"Co-release of glutamate from serotonin terminals","author":"McDevitt","year":"2012"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2595","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0006-3223(03)00530-4","article-title":"Prevalence etiology, and treatment of depression in Parkinson\u2019s disease","volume":"54","author":"McDonald","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2600","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0022-3565(24)35101-8","article-title":"Antagonism of 5-hydroxytryptamine(4) receptors attenuates hyperactivity induced by cocaine: putative role for 5-hydroxytryptamine(4) receptors in the nucleus accumbens shell","volume":"291","author":"McMahon","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2605","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0022-3565(24)29546-X","article-title":"Antagonism of 5-hydroxytryptamine(2a) receptors attenuates the behavioral effects of cocaine in rats","volume":"297","author":"McMahon","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2610","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0893-133X(00)00206-2","article-title":"Role of 5-HT(2a) and 5-HT(2B\/2C) receptors in the behavioral interactions between serotonin and catecholamine reuptake inhibitors","volume":"24","author":"McMahon","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2615","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0091-3057(93)90118-D","article-title":"The 5-HT3 antagonist zacopride attenuates cocaine-induced increases in extracellular dopamine in rat nucleus accumbens","volume":"45","author":"McNeish","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2620","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/283772a0","article-title":"Serotonergic neurones are not involved in action of L-dopa in Parkinson\u2019s disease","volume":"283","author":"Melamed","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2625","first-page":"545","article-title":"Involvement of serotonin in clinical features of Parkinson\u2019s disease and complications of L-DOPA therapy","volume":"69","author":"Melamed","year":"1996","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2630","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0079-6123(08)00909-6","article-title":"In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems","volume":"172","author":"Meltzer","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2635","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0031-6997(25)06671-2","article-title":"Effects of antipsychotic drugs on serotonin receptors","volume":"43","author":"Meltzer","year":"1991","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2640","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.1172\/JCI70678","article-title":"Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype-targeted drugs","volume":"123","author":"Meltzer","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2645","first-page":"390","article-title":"The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs","volume":"25","author":"Meltzer","year":"1989","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2650","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-3565(25)20710-8","article-title":"Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1: D-2 and serotonin2 pKi values","volume":"251","author":"Meltzer","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2655","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.pnpbp.2003.09.010","article-title":"Serotonin receptors: their key role in drugs to treat schizophrenia","volume":"27","author":"Meltzer","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2660","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/npp.2009.176","article-title":"Pimavanserin a serotonin(2A) receptor inverse agonist, for the treatment of parkinson\u2019s disease psychosis","volume":"35","author":"Meltzer","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2665","series-title":"5-HT2C Receptors in the Pathophysiology of Central Nervous of System Disease","first-page":"275","article-title":"The 5-HT2C receptor as a target for schizophrenia","author":"Meltzer","year":"2010"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2670","first-page":"144","article-title":"Dopamine2 receptor occupancy and the action of clozapine: does it make a difference to add a neuroleptic?","volume":"46","author":"Meltzer","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2675","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0006-3223(99)00255-3","article-title":"Treatment of schizophrenia and spectrum disorders: pharmacotherapy psychosocial treatments, and neurotransmitter interactions","volume":"46","author":"Meltzer","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2680","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/npp.2013.332","article-title":"Rapid anxiolytic effects of a 5-HT(4) receptor agonist are mediated by a neurogenesis-independent mechanism","volume":"39","author":"Mendez-David","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2685","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0306-4522(90)90330-7","article-title":"The distribution and cellular-Localization of the serotonin 1c receptor messenger-Rna in the rodent brain examined by insitu hybridization Histochemistry\u2014Comparison with receptor-Binding distribution","volume":"35","author":"Mengod","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2690","series-title":"5-HT2C Receptors in the Pathophysiology of CNS Disease","first-page":"17","article-title":"Serotonin 5-HT2C receptors: chemical neuronatomy in the mammalian brain","author":"Mengod","year":"2011"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2695","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1476-5381.1990.tb15792.x","article-title":"Responses of rat substantia nigra compacta neurones to L-DOPA","volume":"100","author":"Mercuri","year":"1990","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2700","doi-asserted-by":"crossref","first-page":"9344","DOI":"10.1523\/JNEUROSCI.1260-12.2012","article-title":"Striatal dopamine release and genetic variation of the serotonin 2C receptor in humans","volume":"32","author":"Mickey","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2705","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neuropharm.2012.11.016","article-title":"L-DOPA modifies the antidepressant-like effects of reboxetine and fluoxetine in rats","volume":"67","author":"Miguelez","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2710","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fncir.2014.00021","article-title":"Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson\u2019s disease","volume":"8","author":"Miguelez","year":"2014","journal-title":"Front. Neural Circuits"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2715","doi-asserted-by":"crossref","DOI":"10.1111\/bph.13447","article-title":"The acute and long-term L-DOPA effects are independent from changes in the activity of dorsal raphe serotonergic neurons in 6-OHDA lesioned rats","author":"Miguelez","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2720","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0014-2999(97)89962-1","article-title":"5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists","volume":"325","author":"Millan","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2725","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0028-3908(98)00078-1","article-title":"Serotonin (5-HT) 2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA) but not 5-HT, release in the frontal cortex in vivo","volume":"37","author":"Millan","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2730","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0022-3565(24)37732-8","volume":"286","author":"Millan","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2735","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1046\/j.1460-9568.2000.00982.x","article-title":"Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram","volume":"12","author":"Millan","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2740","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/026988110001400202","article-title":"Reciprocal autoreceptor and heteroreceptor control of serotonergic: dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents","volume":"14","author":"Millan","year":"2000","journal-title":"J. Psychopharmacol. (Oxf.)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2745","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1124\/jpet.103.051797","article-title":"The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways","volume":"306","author":"Millan","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2750","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00213-004-1962-z","article-title":"Anxiolytic properties of agomelatine: an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade","volume":"177","author":"Millan","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2755","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.tips.2008.06.007","article-title":"Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions","volume":"29","author":"Millan","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2760","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0301-0082(03)00087-X","article-title":"The neurobiology and control of anxious states","volume":"70","author":"Millan","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2765","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2515\/therapie:2005065","article-title":"Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies","volume":"60","author":"Millan","year":"2005","journal-title":"Therapie"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2770","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pharmthera.2005.11.006","article-title":"Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application","volume":"110","author":"Millan","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2775","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1046\/j.1471-4159.1999.721516.x","article-title":"Role of high-affinity dopamine uptake and impulse activity in the appearance of extracellular dopamine in striatum after administration of exogenous L-DOPA: studies in intact and 6-hydroxydopamine-treated rats","volume":"72","author":"Miller","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2780","first-page":"373","article-title":"Treatment of neuroleptic induced akathisia with the 5-HT2 antagonist ritanserin","volume":"26","author":"Miller","year":"1990","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2785","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0014-2999(91)90163-K","article-title":"The effect of acute and chronic LY 277359 a selective 5-HT3 receptor antagonist, on the number of spontaneously active midbrain dopamine neurons","volume":"209","author":"Minabe","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2790","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0014-2999(91)90162-J","article-title":"The 5-Ht3 receptor antagonists ly-277359 and granisetron potentiate the suppressant action of apomorphine on the basal firing rate of ventral tegmental dopamine cells","volume":"209","author":"Minabe","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2795","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/(SICI)1098-2396(199601)22:1<46::AID-SYN5>3.0.CO;2-I","article-title":"The depletion of brain serotonin levels by para-chlorophenylalanine administration significantly alters the activity of midbrain dopamine cells in rats: an extracellular single cell recording study","volume":"22","author":"Minabe","year":"1996","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2800","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/syn.10255","article-title":"Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study","volume":"50","author":"Minabe","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2805","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/syn.20002","article-title":"Effect of the acute and chronic administration of the selective 5-HT6 receptor antagonist SB-271046 on the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study","volume":"52","author":"Minabe","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2810","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0301-0082(96)00042-1","article-title":"The basal ganglia: focused selection and inhibition of competing motor programs","volume":"50","author":"Mink","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2815","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-3806(94)90099-X","article-title":"Postnatal development and localization of 5-HT1A receptor mRNA in rat forebrain and cerebellum","volume":"80","author":"Miquel","year":"1994","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2820","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.cub.2014.07.041","article-title":"Optogenetic activation of dorsal raphe serotonin neurons enhances patience for future rewards","volume":"24","author":"Miyazaki","year":"2014","journal-title":"Current biology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2825","first-page":"49","article-title":"Expression of 5-HT receptors in prefrontal cortex pyramidal neurons projecting to nucleus accumbens. Potential relevance for atypical antipsychotic action","volume":"79C","author":"Mocci","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2830","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1111\/j.1471-4159.1990.tb01230.x","article-title":"Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex nucleus accumbens, and striatum of the rat: an in vivo microdialysis study","volume":"54","author":"Moghaddam","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2835","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1073\/pnas.86.17.6793","article-title":"5-Ht1c receptor is a prominent serotonin receptor subtype in the central nervous-System","volume":"86","author":"Molineaux","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2840","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.neuropharm.2010.06.009","article-title":"Functional relevance of serotonin 2C receptor mRNA editing in antidepressant- and anxiety-like behaviors","volume":"59","author":"Mombereau","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2845","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0026-895X(25)13616-X","article-title":"Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs","volume":"43","author":"Monsma","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2850","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.smrv.2009.10.003","article-title":"The role of dorsal raphe nucleus serotonergic and non-serotonergic neurons and of their receptors, in regulating waking and rapid eye movement (REM) sleep","volume":"14","author":"Monti","year":"2010","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2855","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1523\/JNEUROSCI.17-09-03157.1997","article-title":"The 5-HT3 receptor is present in different subpopulations of GABAergic neurons in the rat telencephalon","volume":"17","author":"Morales","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2860","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.1523\/JNEUROSCI.22-15-06732.2002","article-title":"Differential composition of 5-hydroxytryptamine3 receptors synthesized in the rat CNS and peripheral nervous system","volume":"22","author":"Morales","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2865","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0006-8993(96)00557-4","article-title":"The type 3 serotonin receptor is expressed in a subpopulation of GABAergic neurons in the rat neocortex and hippocampus","volume":"731","author":"Morales","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2870","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/(SICI)1096-9861(19981221)402:3<385::AID-CNE7>3.0.CO;2-Q","article-title":"Distribution of neurons expressing immunoreactivity for the 5HT3 receptor subtype in the rat brain and spinal cord","volume":"402","author":"Morales","year":"1998","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2875","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/BF02246963","article-title":"Effects of repeated mild stress and two antidepressant treatments on the behavioral response to 5HT1C receptor activation in rats","volume":"110","author":"Moreau","year":"1993","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2880","first-page":"51","article-title":"Curative effects of the atypical antidepressant mianserin in the chronic mild stress-induced anhedonia model of depression","volume":"19","author":"Moreau","year":"1994","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2885","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0924-977X(96)00015-6","article-title":"5HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats","volume":"6","author":"Moreau","year":"1996","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2890","doi-asserted-by":"crossref","first-page":"15742","DOI":"10.1523\/JNEUROSCI.2989-11.2011","article-title":"Chronic 5-HT transporter blockade reduces DA signaling to elicit basal ganglia dysfunction","volume":"31","author":"Morelli","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2895","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0306-4522(93)90241-7","article-title":"Immunocytochemical localization and description of neurons expressing serotonin2 receptors in the rat brain","volume":"54","author":"Morilak","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2900","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s002130050941","article-title":"Biochemical and behavioral anxiolytic-like effects of R(+)HA-966 at the level of the ventral tegmental area in rats","volume":"143","author":"Morrow","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2905","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mds.26103","article-title":"Presynaptic effects of levodopa and their possible role in dyskinesia","volume":"30","author":"Mosharov","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2910","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0306-4522(96)00452-6","article-title":"Quantitative and morphometric data indicate precise cellular interactions between serotonin terminals and postsynaptic targets in rat substantia nigra","volume":"76","author":"Moukhles","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2915","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1093\/brain\/awn235","article-title":"Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia","volume":"131","author":"Munoz","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2920","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0014-2999(88)90591-2","article-title":"5-HT2 antagonists and minaprine block the 5-HT-induced inhibition of dopamine release from rat brain striatal slices","volume":"153","author":"Muramatsu","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2925","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1111\/j.1471-4159.2010.06723.x","article-title":"Distribution of catechol-O-methyltransferase (COMT) proteins and enzymatic activities in wild-type and soluble COMT deficient mice","volume":"113","author":"Myohanen","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2930","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1471-4159.2011.07598.x","article-title":"Serotonergic modulation of receptor occupancy in rats treated with L-DOPA after unilateral 6-OHDA lesioning","volume":"120","author":"Nahimi","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2935","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.brainresbull.2004.02.007","article-title":"Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation","volume":"63","author":"Nakayama","year":"2004","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2940","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.conb.2008.11.001","article-title":"Seven problems on the basal ganglia","volume":"18","author":"Nambu","year":"2008","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2945","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0022-3565(25)20405-0","article-title":"Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors","volume":"259","author":"Nash","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2950","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/0024-3205(90)90484-9","article-title":"Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis","volume":"47","author":"Nash","year":"1990","journal-title":"Life Sci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2955","series-title":"5-HT2C Receptors in the Pathophysiology of CNS Disease","first-page":"187","article-title":"The constitutive activity of 5-HT2C receptors as an additional modality of interaction of the serotonergic system in motor control","author":"Navailles","year":"2010"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2960","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00213-010-2029-y","article-title":"Presynaptic control of serotonin on striatal dopamine function","volume":"213","author":"Navailles","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2965","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12035-011-8230-0","article-title":"Contribution of serotonergic transmission to the motor and cognitive effects of high-frequency stimulation of the subthalamic nucleus or levodopa in Parkinson\u2019s disease","volume":"45","author":"Navailles","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2970","first-page":"323686","article-title":"Imbalanced dopaminergic transmission mediated by serotonergic neurons in L-DOPA-Induced dyskinesia","volume":"2012","author":"Navailles","year":"2012","journal-title":"Parkinson\u2019s disease"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2975","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.npp.1300329","article-title":"In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum","volume":"29","author":"Navailles","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2980","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.biopsych.2005.07.035","article-title":"Clozapine and haloperidol differentially alter the constitutive activity of central serotonin2C receptors in vivo","volume":"59","author":"Navailles","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2985","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/j.1471-4159.2006.04188.x","article-title":"Region-dependent regulation of mesoaccumbens dopamine neurons in vivo by the constitutive activity of central serotonin2C receptors","volume":"99","author":"Navailles","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2990","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/sj.npp.1301414","article-title":"Differential regulation of the mesoaccumbens dopamine circuit by serotonin2C receptors in the ventral tegmental area and the nucleus accumbens: an in vivo microdialysis study with cocaine","volume":"33","author":"Navailles","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib2995","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1523\/JNEUROSCI.5031-09.2010","article-title":"High-frequency stimulation of the subthalamic nucleus and L-3, 4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson\u2019s disease","volume":"30","author":"Navailles","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3000","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.nbd.2010.01.012","article-title":"Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson\u2019s disease","volume":"38","author":"Navailles","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3005","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.nbd.2010.11.007","article-title":"Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson\u2019s disease","volume":"41","author":"Navailles","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2174\/1871524911106040305","article-title":"L-DOPA and serotonergic neurons: functional implication and therapeutic perspectives in Parkinson\u2019s disease","volume":"11","author":"Navailles","year":"2011","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3015","first-page":"1","article-title":"Serotonin2C ligands exhibiting full negative and positive intrinsic activity elicit purposeless oral movements in rats: distinct effects of agonists and inverse agonists in a rat model of Parkinson\u2019s disease","author":"Navailles","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3020","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1021\/cn400046e","article-title":"Multisite intracerebral microdialysis to study the mechanism of L-DOPA induced dopamine and serotonin release in the parkinsonian brain","volume":"4","author":"Navailles","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3025","doi-asserted-by":"crossref","DOI":"10.2174\/1871524911313020002","article-title":"Serotonin2C receptor constitutive activity: In vivo direct and indirect evidence and functional significance","author":"Navailles","year":"2013","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3030","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00221-013-3562-9","article-title":"Role of 5-HT2C receptors in the enhancement of c-Fos expression induced by a 5-HT2B\/2C inverse agonist and 5-HT 2 agonists in the rat basal ganglia","volume":"230","author":"Navailles","year":"2013","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3035","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1017\/S1461145712000417","article-title":"Serotonin2C ligands exhibiting full negative and positive intrinsic activity elicit purposeless oral movements in rats: distinct effects of agonists and inverse agonists in a rat model of Parkinson\u2019s disease","volume":"16","author":"Navailles","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3040","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/cns.12252","article-title":"Predicting dopaminergic effects of L-DOPA in the treatment for Parkinson\u2019s disease","volume":"20","author":"Navailles","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3045","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/cns.12275","article-title":"Noradrenergic terminals regulate L-DOPA-derived dopamine extracellular levels in a region-dependent manner in Parkinsonian rats","volume":"20","author":"Navailles","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3050","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/cns.12436","article-title":"The 5-HT4 agonist prucalopride stimulates L-DOPA-Induced dopamine release in restricted brain regions of the hemiparkinsonian rat In vivo","volume":"21","author":"Navailles","year":"2015","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3055","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0022-3565(25)38100-0","article-title":"Serotonergic involvement in haloperidol-induced catalepsy","volume":"265","author":"Neal-Beliveau","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3060","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/333174a0","article-title":"Facilitation of a dendritic calcium conductance by 5-hydroxytryptamine in the substantia nigra","volume":"333","author":"Nedergaard","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3065","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00001756-199106000-00007","article-title":"Excitation of substantia-nigra pars compacta neurons by 5-Hydroxytryptamine invitro","volume":"2","author":"Nedergaard","year":"1991","journal-title":"Neuroreport"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3070","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1037\/a0021114","article-title":"Dissociable roles of dopamine within the core and medial shell of the nucleus accumbens in memory for objects and place","volume":"124","author":"Nelson","year":"2010","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/1568007043482606","article-title":"5-HT5 receptors","volume":"3","author":"Nelson","year":"2004","journal-title":"Current Drug Targets \u2013 CNS and Neurological Disorders"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3080","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0891-0618(00)00092-2","article-title":"Localization of 5-HT(7) receptors in rat brain by immunocytochemistry in situ hybridization, and agonist stimulated cFos expression","volume":"21","author":"Neumaier","year":"2001","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3085","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1471-4159.2011.07292.x","article-title":"Dopamine release from serotonergic nerve fibers is reduced in L-DOPA-induced dyskinesia","volume":"118","author":"Nevalainen","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3090","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1097\/00001756-199611250-00020","article-title":"5-HT2B receptor mRNA in guinea pig superior cervical ganglion","volume":"7","author":"Newberry","year":"1996","journal-title":"Neuroreport"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3095","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1046\/j.1471-4159.1997.69031031.x","article-title":"Mianserin-induced down-regulation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors stably expressed in the human neuroblastoma cell line SH-SY5Y","volume":"69","author":"Newton","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3100","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1126\/science.170.3953.76","article-title":"L-Dopa-induced release of cerebral monoamines","volume":"170","author":"Ng","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3105","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1212\/WNL.22.7.688","article-title":"L-dopa in Parkinsonism. A possible mechanism of action","volume":"22","author":"Ng","year":"1972","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3110","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/(SICI)1097-4547(19990301)55:5<600::AID-JNR7>3.0.CO;2-#","article-title":"Regulation of striatal dopamine release through 5-HT1 and 5-HT2 receptors","volume":"55","author":"Ng","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3115","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.0953-816x.2001.01644.x","article-title":"Effect of microiontophoretic application of dopamine on subthalamic nucleus neuronal activity in normal rats and in rats with unilateral lesion of the nigrostriatal pathway","volume":"14","author":"Ni","year":"2001","journal-title":"Eur. J. Neurosci."},{"issue":"Suppl. (9)","key":"10.1016\/j.pneurobio.2016.03.004_bib3120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1468-1331.9.s3.1.x","article-title":"5-hydroxytryptamine (5-HT: serotonin) and Parkinson\u2019s disease \u2013 opportunities for novel therapeutics to reduce the problems of levodopa therapy","volume":"3","author":"Nicholson","year":"2002","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3125","doi-asserted-by":"crossref","first-page":"9472","DOI":"10.1074\/jbc.274.14.9472","article-title":"RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity","volume":"274","author":"Niswender","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3130","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0893-133X(00)00223-2","article-title":"RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy","volume":"24","author":"Niswender","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3135","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0306-4522(01)00593-0","article-title":"Localization of 5-HT2A receptors on dopamine cells in subnuclei of the midbrain A10 cell group","volume":"111","author":"Nocjar","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3140","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1471-4159.2003.01518.x","article-title":"Recombinant human serotonin 5A receptors stably expressed in C6 glioma cells couple to multiple signal transduction pathways","volume":"84","author":"Noda","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3145","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0169-328X(95)00004-C","article-title":"Increased expression of 5HT2 receptor mRNA in rat striatum following 6-OHDA lesions of the adult nigrostriatal pathway","volume":"29","author":"Numan","year":"1995","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3150","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/BF01268873","article-title":"Characterization of the effects of serotonin on the release of [3H]dopamine from rat nucleus accumbens and striatal slices","volume":"13","author":"Nurse","year":"1988","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3155","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1124\/jpet.104.069278","article-title":"Serotonin1B receptors in the ventral tegmental area modulate cocaine-induced increases in nucleus accumbens dopamine levels","volume":"311","author":"O\u2019Dell","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3160","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0091-3057(98)00240-8","article-title":"5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB","volume":"63","author":"O\u2019Neill","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3165","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.1523\/JNEUROSCI.15-09-05859.1995","article-title":"Distribution of pontomesencephalic cholinergic neurons projecting to substantia nigra differs significantly from those projecting to ventral tegmental area","volume":"15","author":"Oakman","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3170","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1254\/jphs.08313FP","article-title":"Effects of tandospirone a 5-HT1A agonistic anxiolytic agent, on haloperidol-induced catalepsy and forebrain Fos expression in mice","volume":"109","author":"Ohno","year":"2009","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3175","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.neuropharm.2003.10.003","article-title":"5-HT2 receptors differentially modulate dopamine-mediated Auto-inhibition in A9 and A10 midbrain areas of the rat","volume":"46","author":"Olijslagers","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3180","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejphar.2005.08.014","article-title":"The role of 5-HT(2A) receptor antagonism in amphetamine-induced inhibition of A10 dopamine neurons in vitro","volume":"520","author":"Olijslagers","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3185","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/157015906775203020","article-title":"Modulation of midbrain dopamine neurotransmission by serotonin: a versatile interaction between neurotransmitters and significance for antipsychotic drug action","volume":"4","author":"Olijslagers","year":"2006","journal-title":"Current Neuropharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3190","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/srep01447","article-title":"The real catecholamine content of secretory vesicles in the CNS revealed by electrochemical cytometry","volume":"3","author":"Omiatek","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3195","article-title":"Serotonin 2C receptor antagonists induce fast-onset antidepressant effects","author":"Opal","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3200","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1212\/WNL.53.5.1154-a","article-title":"Mirtazapine treats resting tremor, essential tremor, and levodopa-induced dyskinesias","volume":"53","author":"Pact","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3205","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1007\/BF02245008","article-title":"Electrophysiological: biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function","volume":"112","author":"Palfreyman","year":"1993","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3210","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(99)00058-0","article-title":"Chronic but not acute clomipramine alters the effect of NMDA receptor regulation of dopamine release in rat frontal cortex","volume":"262","author":"Pallotta","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3215","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1586\/14737175.6.11.1595","article-title":"Could agomelatine be the ideal antidepressant?","volume":"6","author":"Pandi-Perumal","year":"2006","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3220","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1111\/j.1460-9568.2003.03015.x","article-title":"Depression of mGluR-mediated IPSCs by 5-HT in dopamine neurons of the rat substantia nigra pars compacta","volume":"18","author":"Paolucci","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3225","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0006-8993(93)90984-U","article-title":"Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis","volume":"606","author":"Parsons","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3230","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/(SICI)1098-2396(199905)32:2<132::AID-SYN6>3.0.CO;2-V","article-title":"RU 24969 a 5-HT1B\/1A receptor agonist, potentiates cocaine-induced increases in nucleus accumbens dopamine","volume":"32","author":"Parsons","year":"1999","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3235","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/0306-4522(95)00314-9","article-title":"Localization of serotonin-4 receptors in the striatonigral pathway in rat-Brain","volume":"69","author":"Patel","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3240","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00005072-199111000-00006","article-title":"The neuropathologic basis of different clinical subgroups of Parkinson\u2019s disease","volume":"50","author":"Paulus","year":"1991","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3245","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-8993(85)90856-X","article-title":"Quantitative autoradiographic mapping of serotonin receptors in the rat brain: i. Serotonin-1 receptors","volume":"346","author":"Pazos","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3250","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0278-5846(97)00040-7","article-title":"Ritanserin administration potentiates amphetamine-stimulated dopamine release in the rat prefrontal cortex","volume":"21","author":"Pehek","year":"1997","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3255","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0006-8993(00)03004-3","article-title":"M100,907 a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex","volume":"888","author":"Pehek","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3260","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.npp.1300819","article-title":"Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex","volume":"31","author":"Pehek","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3265","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1098-2396(199609)24:1<12::AID-SYN2>3.0.CO;2-J","article-title":"Local infusion of the serotonin antagonists ritanserin or ICS 205,930 increases in vivo dopamine release in the rat medial prefrontal cortex","volume":"24","author":"Pehek","year":"1996","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3270","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0014-2999(93)90410-J","article-title":"5-HT3 receptor antagonists inhibit morphine-induced stimulation of mesolimbic dopamine release and function in the rat","volume":"230","author":"Pei","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3275","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1111\/j.1460-9568.2005.04110.x","article-title":"DeltaFosB accumulates in a GABAergic cell population in the posterior tail of the ventral tegmental area after psychostimulant treatment","volume":"21","author":"Perrotti","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3280","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/0024-3205(92)90423-M","article-title":"Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum","volume":"50","author":"Perry","year":"1992","journal-title":"Life Sci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3285","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/0006-8993(94)90495-2","article-title":"Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro","volume":"654","author":"Pessia","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3290","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1097\/00001756-199512150-00019","article-title":"Origin of the dopaminergic innervation of the rat dorsal raphe nucleus","volume":"6","author":"Peyron","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3295","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1124\/jpet.103.062208","article-title":"Stimulation of serotonin2C receptors blocks the hyperactivation of midbrain dopamine neurons induced by nicotine administration","volume":"309","author":"Pierucci","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3300","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1124\/jpet.103.062208","article-title":"Stimulation of serotonin2C receptors blocks the hyperactivation of midbrain dopamine neurons induced by nicotine administration","volume":"309","author":"Pierucci","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3305","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0306-4522(91)90080-8","article-title":"Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey","volume":"44","author":"Pifl","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3310","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.nbd.2010.05.028","article-title":"Staging of serotonergic dysfunction in Parkinson\u2019s disease: an in vivo 11C-DASB PET study","volume":"40","author":"Politis","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3315","doi-asserted-by":"crossref","first-page":"128ra141","DOI":"10.1126\/scitranslmed.3003391","article-title":"Serotonin neuron loss and nonmotor symptoms continue in Parkinson\u2019s patients treated with dopamine grafts","volume":"4","author":"Politis","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3320","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1172\/JCI71640","article-title":"Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson\u2019s disease patients","volume":"124","author":"Politis","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3325","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1523\/JNEUROSCI.12-02-00440.1992","article-title":"Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding","volume":"12","author":"Pompeiano","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3330","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0169-328X(94)90223-2","article-title":"Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors","volume":"23","author":"Pompeiano","year":"1994","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3335","doi-asserted-by":"crossref","first-page":"20812","DOI":"10.1074\/jbc.M112216200","article-title":"5-Hydroxytryptamine 4(a) receptor is coupled to the Galpha subunit of heterotrimeric G13 protein","volume":"277","author":"Ponimaskin","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3340","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0028-3908(02)00212-5","article-title":"Central serotonin4 receptors selectively regulate the impulse-dependent exocytosis of dopamine in the rat striatum: in vivo studies with morphine, amphetamine and cocaine","volume":"43","author":"Porras","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3345","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0028-3908(02)00212-5","article-title":"Central serotonin(4) receptors selectively regulate the impulse-dependent exocytosis of dopamine in the rat striatum: in vivo studies with morphine, amphetamine and cocaine","volume":"43","author":"Porras","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3350","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0893-133X(01)00333-5","article-title":"5-HT2A and 5-HT2C\/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum","volume":"26","author":"Porras","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3355","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1046\/j.1460-9568.2003.02512.x","article-title":"Conditional involvement of striatal serotonin3 receptors in the control of in vivo dopamine outflow in the rat striatum","volume":"17","author":"Porras","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3360","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1038\/srep03730","article-title":"L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum","volume":"4","author":"Porras","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3365","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0006-8993(95)00595-H","article-title":"Intranigral GR-113808 a selective 5-HT4 receptor antagonist, attenuates morphine-stimulated dopamine release in the rat striatum","volume":"692","author":"Pozzi","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3370","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1471-4159.2002.00947.x","article-title":"Stimulation of 5-hydroxytryptamine (5-HT(2C)) receptors in the ventrotegmental area inhibits stress-induced but not basal dopamine release in the rat prefrontal cortex","volume":"82","author":"Pozzi","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0922-4106(93)90052-B","article-title":"Novel regulation of 5-HT1C receptors: down-regulation induced both by 5-HT1C\/2 receptor agonists and antagonists","volume":"244","author":"Pranzatelli","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3380","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-2999(99)00859-6","article-title":"The effects of antipsychotics with 5-HT(2C) receptor affinity in behavioral assays selective for 5-HT(2C) receptor antagonist properties of compounds","volume":"388","author":"Prinssen","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3385","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0014-2999(02)02430-5","article-title":"5-HT1A receptor activation and anti-cataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy","volume":"453","author":"Prinssen","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3390","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1111\/j.1476-5381.1995.tb16684.x","article-title":"Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area","volume":"116","author":"Prisco","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3395","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0014-2999(92)90089-M","article-title":"Chronic treatment with dau-6215 a new 5-Ht3 receptor antagonist, causes a selective decrease in the number of spontaneously active dopaminergic-Neurons in the rat ventral tegmental area","volume":"214","author":"Prisco","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3400","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-3565(25)22843-9","article-title":"Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo","volume":"271","author":"Prisco","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3405","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0006-8993(91)90192-X","article-title":"Acute stress induces time-dependent responses in dopamine mesolimbic system","volume":"554","author":"Puglisi-Allegra","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3410","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1471-4159.1980.tb04625.x","article-title":"Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on neurotransmitter systems in subcortical sites in the rat","volume":"34","author":"Pycock","year":"1980","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3415","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/286074a0","article-title":"Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats","volume":"286","author":"Pycock","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3420","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1476-5381.2009.00406.x","article-title":"Further pharmacological characterization of 5-HT(2C) receptor agonist-induced inhibition of 5-HT neuronal activity in the dorsal raphe nucleus in vivo","volume":"158","author":"Queree","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3425","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/syn.890010115","article-title":"Differential effects of selective lesions of cholinergic and dopaminergic neurons on serotonin-type 1 receptors in rat brain","volume":"1","author":"Quirion","year":"1987","journal-title":"Synapse"},{"issue":"Suppl (4)","key":"10.1016\/j.pneurobio.2016.03.004_bib3430","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S1353-8020(09)70846-6","article-title":"Hallucinations and psychosis in Parkinson\u2019s disease","volume":"15","author":"Rabey","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-0186(91)90029-D","article-title":"Autoradiography of serotonin receptor subtypes in the central nervous system","volume":"18","author":"Radja","year":"1991","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3440","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0006-8993(93)90995-Y","article-title":"Serotonin 5-HT1 and 5-HT2 receptors in adult rat brain after neonatal destruction of nigrostriatal dopamine neurons: a quantitative autoradiographic study","volume":"606","author":"Radja","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3445","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0014-2999(75)90239-3","article-title":"d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes","volume":"34","author":"Raiteri","year":"1975","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3450","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1152\/jn.00507.2009","article-title":"Transient firing of dorsal raphe neurons encodes diverse and specific sensory motor, and reward events","volume":"102","author":"Ranade","year":"2009","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3455","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0014-2999(91)90781-K","article-title":"The 5-Ht3 receptor antagonist zatosetron decreases the number of spontaneously active A10 dopamine neurons","volume":"205","author":"Rasmussen","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3460","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/syn.890180307","article-title":"5-HT1a agonist +\/\u22128-OH-DPAT modulates basal and stress-induced changes in medial prefrontal cortical dopamine","volume":"18","author":"Rasmusson","year":"1994","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3465","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-3565(24)29304-6","article-title":"Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor","volume":"299","author":"Rauser","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3470","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/mds.21382","article-title":"Diagnostic criteria for psychosis in Parkinson\u2019s disease: report of an NINDS: NIMH work group","volume":"22","author":"Ravina","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3475","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/sj.bjp.0702350","article-title":"Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist","volume":"126","author":"Reavill","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3480","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1476-5381.1995.tb13303.x","article-title":"5-Hydroxytryptamine (5-HT) 4 receptors in post mortem human brain tissue: distribution: pharmacology and effects of neurodegenerative diseases","volume":"114","author":"Reynolds","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3485","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2011.04.028","article-title":"ST1936 stimulates cAMP Ca2+, ERK1\/2 and Fyn kinase through a full activation of cloned human 5-HT6 receptors","volume":"661","author":"Riccioni","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3490","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/sj.npp.1301305","article-title":"Dopamine and serotonin receptor binding and antipsychotic efficacy","volume":"32","author":"Richtand","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3495","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0079-6123(08)00908-4","article-title":"Role of serotonin and dopamine receptor binding in antipsychotic efficacy","volume":"172","author":"Richtand","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3500","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0006-8993(02)02360-0","article-title":"The distribution of 5-HT6 receptors in rat brain: an autoradiographic binding study using the radiolabelled 5-HT6 receptor antagonist [I-125]SB-258585","volume":"934","author":"Roberts","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3505","doi-asserted-by":"crossref","first-page":"10039","DOI":"10.1523\/JNEUROSCI.22-22-10039.2002","article-title":"Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice","volume":"22","author":"Rocha","year":"2002","journal-title":"J. Neurosci."},{"issue":"Suppl (3)","key":"10.1016\/j.pneurobio.2016.03.004_bib3510","first-page":"111","article-title":"The subthalamic nucleus and tremor in Parkinson\u2019s disease","volume":"13","author":"Rodriguez","year":"1998","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3515","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S1734-1140(13)71515-9","article-title":"Combined treatment with atypical antipsychotics and antidepressants in treatment-resistant depression: preclinical and clinical efficacy","volume":"65","author":"Rogoz","year":"2013","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3520","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0006-3223(00)00850-7","article-title":"5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex","volume":"48","author":"Rollema","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3525","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0163-8343(92)90100-O","article-title":"Clozapine for the treatment of levodopa-induced psychosis in Parkinson\u2019s disease","volume":"14","author":"Rosenthal","year":"1992","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3530","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1358\/dnp.2007.20.9.1162244","article-title":"5-HT2C receptor agonists as an innovative approach for psychiatric disorders","volume":"20","author":"Rosenzweig-Lipson","year":"2007","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3535","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-3-642-25758-2_6","article-title":"5-HT(2C) agonists as therapeutics for the treatment of schizophrenia","author":"Rosenzweig-Lipson","year":"2012","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3540","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0022-3565(25)11452-3","article-title":"Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors","volume":"260","author":"Roth","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3545","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0022-3565(25)38596-4","article-title":"Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors","volume":"268","author":"Roth","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3550","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/bbrc.1993.1619","article-title":"A novel rat serotonin (5-Ht6) receptor \u2212 molecular-Cloning: localization and stimulation of camp accumulation","volume":"193","author":"Ruat","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3555","doi-asserted-by":"crossref","first-page":"8547","DOI":"10.1073\/pnas.90.18.8547","article-title":"Molecular cloning characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation","volume":"90","author":"Ruat","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3560","doi-asserted-by":"crossref","first-page":"8547","DOI":"10.1073\/pnas.90.18.8547","article-title":"Molecular-Cloning characterization, and localization of a high-Affinity serotonin receptor (5-Ht(7)) activating camp formation","volume":"90","author":"Ruat","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3565","first-page":"2134","article-title":"Distribution of serotonin and synthesizing enzymes in discrete areas of the brain","volume":"36","author":"Saavedra","year":"1977","journal-title":"Fed. Proc."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3570","article-title":"Role of the organic cation transporter (OCT-3) and monoamine oxidase types a and B in the metabolism of dopamine derived from L-DOPA in rat striatum depleted of dopaminergic and serotonergic afferent inputs","author":"Sader-Mazbar","year":"2012","journal-title":"The Tenth International Catecholamine Symposium"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3575","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.bjp.0703139","article-title":"Postsynaptic 5-hydroxytryptamine(1A) receptor activation increases in vivo dopamine release in rat prefrontal cortex","volume":"129","author":"Sakaue","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3580","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/BF02245133","article-title":"Complex motor and sensorimotor functions of striatal and accumbens dopamine: involvement in instrumental behavior processes","volume":"107","author":"Salamone","year":"1992","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3585","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/0024-3205(89)90206-3","article-title":"Dopamine receptor occupancy in vivo: measurement using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ)","volume":"45","author":"Saller","year":"1989","journal-title":"Life Sci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3590","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF02245655","article-title":"Reversal of antidepressant action by dopamine antagonists in an animal model of depression","volume":"104","author":"Sampson","year":"1991","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3595","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/archneur.1996.00550120077019","article-title":"Visual hallucinations associated with Parkinson disease","volume":"53","author":"Sanchez-Ramos","year":"1996","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3600","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/cercor\/bhh070","article-title":"Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex","volume":"14","author":"Santana","year":"2004","journal-title":"Cerebral Cortex (New York, N.Y.: 1991)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3605","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1476-5381.1995.tb16371.x","article-title":"5-HT3 receptor agonist induced carrier-mediated release of dopamine in rat striatum in vivo","volume":"116","author":"Santiago","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3610","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/(SICI)1097-4547(19980601)52:5<591::AID-JNR11>3.0.CO;2-5","article-title":"Influence of serotoninergic drugs on in vivo dopamine extracellular output in rat striatum","volume":"52","author":"Santiago","year":"1998","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3615","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s002109900067","article-title":"Differential sensitivity of 5-HT1B auto and heteroreceptors","volume":"360","author":"Sarhan","year":"1999","journal-title":"Naunyn-Schmiedeberg\u2019s archives of pharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3620","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/PL00005321","article-title":"5-HT1B receptors modulate release of [3H]dopamine from rat striatal synaptosomes","volume":"359","author":"Sarhan","year":"1999","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3625","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s002109900163","article-title":"5-HT1B receptors modulate release of [3H]dopamine from rat striatal synaptosomes: further evidence using 5-HT moduline, polyclonal 5-HT1B receptor antibodies and 5-HT1B receptor knock-out mice","volume":"361","author":"Sarhan","year":"2000","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3630","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0006-8993(97)00400-9","article-title":"Light and electron microscopic immunocytochemical visualization of 5-HT1B receptors in the rat brain","volume":"760","author":"Sari","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3635","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0306-4522(98)00256-5","article-title":"Cellular and subcellular localization of 5-hydroxytryptamine1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies","volume":"88","author":"Sari","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3640","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1152\/jn.1994.71.2.515","article-title":"The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task","volume":"71","author":"Sawaguchi","year":"1994","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3645","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00213-010-1928-2","article-title":"The role of serotonin-2 (5-HT2) and dopamine receptors in the behavioral actions of the 5-HT2A\/2C agonist DOI, and putative 5-HT2C inverse agonist, SR46349B","volume":"213","author":"Scarlota","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3650","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/sj.npp.1301503","article-title":"Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: wAY-181187 and WAY-208466","volume":"33","author":"Schechter","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3655","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/syn.20853","article-title":"Effects of S-citalopram, citalopram, and R-citalopram on the firing patterns of dopamine neurons in the ventral tegmental area, N-methyl-D-aspartate receptor-mediated transmission in the medial prefrontal cortex and cognitive function in the rat","volume":"65","author":"Schilstrom","year":"2011","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3660","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0014-2999(89)90595-5","article-title":"The putative 5-HT3 agonist phenylbiguanide induces carrier-mediated release of [3H]dopamine","volume":"167","author":"Schmidt","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3665","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0022-3565(25)13106-6","article-title":"Regional effects of MK-801 on dopamine release: effects of competitive NMDA or 5-HT2A receptor blockade","volume":"277","author":"Schmidt","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3670","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0014-2999(92)90743-N","article-title":"The 5-HT2 receptor antagonist MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamine","volume":"220","author":"Schmidt","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3675","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0014-2999(92)90819-P","article-title":"5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue 3,4-methylenedioxymethamphetamine","volume":"223","author":"Schmidt","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3680","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1046\/j.1471-4159.1994.62041382.x","article-title":"Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine","volume":"62","author":"Schmidt","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3685","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/0024-3205(95)00210-W","article-title":"The role of 5-HT2A receptors in antipsychotic activity","volume":"56","author":"Schmidt","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3690","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0014-5793(94)80590-3","article-title":"Cloning and functional characterization of the human 5-HT2B serotonin receptor","volume":"342","author":"Schmuck","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3695","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/01.WNF.0000229013.95927.C7","article-title":"Challenging the serotonergic system in Parkinson disease patients: effects on cognition mood, and motor performance","volume":"29","author":"Scholtissen","year":"2006","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3700","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00702-005-0368-3","article-title":"Serotonergic mechanisms in Parkinson\u2019s disease: opposing results from preclinical and clinical data","volume":"113","author":"Scholtissen","year":"2006","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3705","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0006-8993(89)90325-9","article-title":"Receptor occupancy by ritanserin and risperidone measured using ex vivo autoradiography","volume":"500","author":"Schotte","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3710","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0006-8993(93)91535-Z","article-title":"Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol: measured ex vivo by quantitative autoradiography","volume":"631","author":"Schotte","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3715","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3720","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1523\/JNEUROSCI.13-03-00900.1993","article-title":"Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task","volume":"13","author":"Schultz","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3725","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/cercor\/10.3.272","article-title":"Reward processing in primate orbitofrontal cortex and basal ganglia","volume":"10","author":"Schultz","year":"2000","journal-title":"Cerebral Cortex (New York, N.Y.: 1991)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3730","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1744-9081-6-24","article-title":"Dopamine signals for reward value and risk: basic and recent data","volume":"6","author":"Schultz","year":"2010","journal-title":"Behav. Brain Funct."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3735","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1152\/physrev.00023.2014","article-title":"Neuronal reward and decision signals: from theories to data","volume":"95","author":"Schultz","year":"2015","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3740","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0006-8993(89)91189-X","article-title":"Fenfluramine administered systemically or locally increases extracellular serotonin in the lateral hypothalamus as measured by microdialysis","volume":"482","author":"Schwartz","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3745","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/j.1471-4159.1980.tb07867.x","article-title":"The relationship between the stimulation of dopamine synthesis and release produced by amphetamine and high potassium in striatal slices","volume":"35","author":"Schwarz","year":"1980","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3750","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.neuroscience.2010.09.058","article-title":"Phasic responses in dorsal raphe serotonin neurons to noxious stimuli","volume":"171","author":"Schweimer","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3755","doi-asserted-by":"crossref","first-page":"7673","DOI":"10.1073\/pnas.97.14.7673","article-title":"Schizophrenia: more dopamine: more D2 receptors","volume":"97","author":"Seeman","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3760","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/261717a0","article-title":"Antipsychotic drug doses and neuroleptic\/dopamine receptors","volume":"261","author":"Seeman","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3765","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1146\/annurev.pa.33.040193.003231","article-title":"Amphetamine: effects on catecholamine systems and behavior","volume":"33","author":"Seiden","year":"1993","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3770","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/syn.20349","article-title":"Acute and repeated administration of fluoxetine citalopram, and paroxetine significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study","volume":"61","author":"Sekine","year":"2007","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3775","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jchemneu.2004.03.010","article-title":"Expression of serotonin 5-HT2C receptors in GABAergic cells of the anterior raphe nuclei","volume":"29","author":"Serrats","year":"2005","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3780","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1517\/14728222.8.1.15","article-title":"The 5-HT2C receptor as a target for mood disorders","volume":"8","author":"Serretti","year":"2004","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3785","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0361-9230(00)00358-0","article-title":"Serotonin-mediated striatal dopamine release involves the dopamine uptake site and the serotonin receptor","volume":"53","author":"Sershen","year":"2000","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3790","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/npp.2009.93","article-title":"Cortico-Basal Ganglia reward network: microcircuitry","volume":"35","author":"Sesack","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3795","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/cne.903200202","article-title":"Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area","volume":"320","author":"Sesack","year":"1992","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3800","first-page":"315","article-title":"Brain monoamines in the rhesus monkey during long-term neuroleptic administration","volume":"24","author":"Shannak","year":"1980","journal-title":"Adv. Biochem. Psychopharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3805","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1471-4159.1989.tb07319.x","article-title":"In vivo measurement of extracellular 5-hydroxytryptamine in hippocampus of the anaesthetized rat using microdialysis: changes in relation to 5-hydroxytryptaminergic neuronal activity","volume":"53","author":"Sharp","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3810","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0022-3565(25)28709-2","article-title":"Kinetics of serotonin accumulation into slices from rat brain: relationship to catecholamine uptake","volume":"175","author":"Shaskan","year":"1970","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3815","doi-asserted-by":"crossref","first-page":"18200","DOI":"10.1016\/S0021-9258(17)46830-X","article-title":"Molecular-cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype","volume":"268","author":"Shen","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3820","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jpsychires.2014.02.012","article-title":"A 6-week randomized double-blind, placebo-controlled, comparator referenced trial of vabicaserin in acute schizophrenia","volume":"53","author":"Shen","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3825","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0022-3565(25)10609-5","article-title":"Ritanserin a 5-HT2A\/2C antagonist, reverses direct dopamine agonist-induced inhibition of midbrain dopamine neurons","volume":"274","author":"Shi","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3830","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0022-3565(25)10609-5","article-title":"Ritanserin a 5-Ht2a\/2c antagonist, reverses direct dopamine agonist-Induced inhibition of midbrain dopamine neurons","volume":"274","author":"Shi","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3835","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1038\/sj.npp.1300534","article-title":"Psychostimulants induce low-frequency oscillations in the firing activity of dopamine neurons","volume":"29","author":"Shi","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3840","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1152\/jn.00317.2005","article-title":"Slow oscillatory firing: a major firing pattern of dopamine neurons in the ventral tegmental area","volume":"94","author":"Shi","year":"2005","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3845","first-page":"103","article-title":"Electrophysiological characteristics of dopamine neurons: a 35-year update","author":"Shi","year":"2009","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3850","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/sj.npp.1300591","article-title":"The effect of clozapine on extracellular dopamine levels in the shell subregion of the rat nucleus accumbens is reversed following chronic administration: comparison with a selective 5-HT(2C) receptor antagonist","volume":"30","author":"Shilliam","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3855","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.pnpbp.2010.04.005","article-title":"Role of cortical and striatal 5-HT1A receptors in alleviating antipsychotic-induced extrapyramidal disorders","volume":"34","author":"Shimizu","year":"2010","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3860","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.expneurol.2014.04.011","article-title":"Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson\u2019s disease","volume":"257","author":"Shin","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3865","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0014-2999(88)90380-9","article-title":"Electrophysiological evidence for a functional-Differentiation between subtypes of the 5-Ht1 receptor","volume":"157","author":"Sinton","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3870","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0014-2999(88)90380-9","article-title":"Electrophysiological evidence for a functional differentiation between subtypes of the 5-HT1 receptor","volume":"157","author":"Sinton","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3875","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fncel.2013.00200","article-title":"Subset specification of central serotonergic neurons","volume":"7","author":"Smidt","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3880","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1124\/mol.110.069278","article-title":"Risperidone-induced inactivation and clozapine-induced reactivation of rat cortical astrocyte 5-hydroxytryptamine(7) receptors: evidence for in situ G protein-coupled receptor homodimer protomer cross-talk","volume":"79","author":"Smith","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3885","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0006-8993(89)90486-1","article-title":"Serotonin innervation in adult rat neostriatum: iI. Ultrastructural features: a radioautographic and immunocytochemical study","volume":"481","author":"Soghomonian","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3890","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0014-2999(89)90402-0","article-title":"Effect of acute and chronic mdl-73,147ef a 5-Ht3 receptor antagonist, on A9 and A10 dopamine neurons","volume":"163","author":"Sorensen","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3895","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0022-3565(25)38366-7","article-title":"Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies","volume":"266","author":"Sorensen","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3900","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0022-3565(25)38366-7","article-title":"Characterization of the 5-Ht(2) receptor antagonist mdl 100907 as a putative atypical antipsychotic \u2013 behavioral, electrophysiological and neurochemical studies","volume":"266","author":"Sorensen","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3905","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0306-4522(84)90082-4","article-title":"Functional aspects of serotonin transmission in the basal ganglia: a review and an in vivo approach using the push-pull cannula technique","volume":"13","author":"Soubrie","year":"1984","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3910","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1471-4159.1985.tb04092.x","article-title":"Serotonin agonists reduce dopamine synthesis in the striatum only when the impulse flow of nigro-striatal neurons is intact","volume":"45","author":"Spampinato","year":"1985","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3915","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0166-2236(99)01447-2","article-title":"The dopamine hypothesis of reward: past and current status","volume":"22","author":"Spanagel","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3920","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.4088\/JCP.10bs06601gry","article-title":"The serotonin-7 receptor as a novel therapeutic target","volume":"71","author":"Stahl","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3925","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.neuron.2013.08.023","article-title":"A unique population of ventral tegmental area neurons inhibits the lateral habenula to promote reward","volume":"80","author":"Stamatakis","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3930","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.neuropharm.2005.09.003","article-title":"5-Hydroxytryptamine induced excitation and inhibition in the subthalamic nucleus: action at 5-HT(2C): 5-HT(4) and 5-HT(1A) receptors","volume":"49","author":"Stanford","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3935","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neuropharm.2012.11.010","article-title":"L-dopa-induced dopamine synthesis and oxidative stress in serotonergic cells","volume":"67","author":"Stansley","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3940","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1124\/jpet.114.218966","article-title":"Chronic L-dopa decreases serotonin neurons in a subregion of the dorsal raphe nucleus","volume":"351","author":"Stansley","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3945","first-page":"157","article-title":"The nucleus raphe dorsalis of the rat and its projection upon the caudatoputamen. A combined cytoarchitectonic, immunohistochemical and retrograde transport study","volume":"77","author":"Steinbusch","year":"1981","journal-title":"J. Physiol. (Paris)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3950","series-title":"Handbook of Chemical Neuroanatomy\u2014Classical Transmitters and Transmitters Receptors in the CNS Part II","first-page":"68","article-title":"Serotonin-immunoreactive neurons and their projections in the CNS","author":"Steinbusch","year":"1984"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3955","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0014-2999(93)90073-Q","article-title":"Reduced levels of 5-HT3 receptor recognition sites in the putamen of patients with Huntington\u2019s disease","volume":"242","author":"Steward","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3960","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1476-5381.1996.tb15154.x","article-title":"Ability of 5-HT4 receptor ligands to modulate rat striatal dopamine release in vitro and in vivo","volume":"117","author":"Steward","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3965","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/brain\/awu409","article-title":"Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson\u2019s disease: a Dose-finding study","volume":"138","author":"Svenningsson","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3970","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0028-3908(93)90069-F","article-title":"Partial dopamine receptor agonists reverse behavioral: biochemical and neuroendocrine effects of neuroleptics in the rat: potential treatment of extrapyramidal side effects","volume":"32","author":"Svensson","year":"1993","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3975","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1097\/00004714-199502001-00003","article-title":"Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism [corrected]","volume":"15","author":"Svensson","year":"1995","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3980","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejphar.2005.06.012","article-title":"Effects of a 5-HT7 receptor antagonist DR4004 on the exploratory behavior in a novel environment and on brain monoamine dynamics in mice","volume":"518","author":"Takeda","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3985","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.neuropharm.2011.01.006","article-title":"Serotonin-dependent depression in Parkinson\u2019s disease: a role for the subthalamic nucleus?","volume":"61","author":"Tan","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3990","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00001756-199902250-00034","article-title":"Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats","volume":"10","author":"Tanaka","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib3995","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02244785","article-title":"Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential?","volume":"115","author":"Tanda","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4000","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF02246048","article-title":"Local 5HT3 receptors mediate fluoxetine but not desipramine-induced increase of extracellular dopamine in the prefrontal cortex","volume":"119","author":"Tanda","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4005","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF02246169","article-title":"Mianserin markedly and selectively increases extracellular dopamine in the prefrontal cortex as compared to the nucleus accumbens of the rat","volume":"123","author":"Tanda","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF02805978","article-title":"Chronic desipramine and fluoxetine differentially affect extracellular dopamine in the rat prefrontal cortex","volume":"127","author":"Tanda","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4015","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/archneur.1996.00550020087019","article-title":"The occurrence of depression in Parkinson\u2019s disease. A community-based study","volume":"53","author":"Tandberg","year":"1996","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4020","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.pnpbp.2012.04.008","article-title":"Modulation of antipsychotic-induced extrapyramidal side effects by medications for mood disorders","volume":"38","author":"Tatara","year":"2012","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pharmthera.2011.10.007","article-title":"A new approach for studying GPCR dimers: drug-induced inactivation and reactivation to reveal GPCR dimer function in vitro in primary culture, and in vivo","volume":"133","author":"Teitler","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4030","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0006-8993(77)90154-8","article-title":"The topographical distribution of serotoninergic terminals in the neostriatum of the rat and the caudate nucleus of the cat","volume":"121","author":"Ternaux","year":"1977","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4035","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.108.147793","article-title":"Role of 5-hydroxytryptamine2C receptors in Ca2+-dependent ethanol potentiation of GABA release onto ventral tegmental area dopamine neurons","volume":"329","author":"Theile","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4040","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1044-7431(03)00131-3","article-title":"Targeting conditional gene modification into the serotonin neurons of the dorsal raphe nucleus by viral delivery of the Cre recombinase","volume":"24","author":"Thevenot","year":"2003","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4045","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s004150200059","article-title":"Subthalamic nucleus stimulation in Parkinson\u2019s disease: clinical evaluation of 18 patients","volume":"249","author":"Thobois","year":"2002","journal-title":"J. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4050","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0006-8993(98)00336-9","article-title":"Dopaminergic regulation of serotonin release in the substantia nigra of the freely moving rat using microdialysis","volume":"796","author":"Thorre","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF02251134","article-title":"The metabolism of exogenous L-dopa in the brain: an immunohistochemical study of its conversion to dopamine in non-catecholaminergic cells of the rat brain","volume":"3","author":"Tison","year":"1991","journal-title":"J. Neural Transm. Park. Dis. Dement. Sect."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4060","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1476-5381.1995.tb16327.x","article-title":"Characterization and distribution of putative 5-ht7 receptors in guinea-pig brain","volume":"115","author":"To","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4065","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0091-3057(01)00710-9","article-title":"An investigation of the role of 5-HT(2C) receptors in modifying ethanol self-administration behaviour","volume":"71","author":"Tomkins","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4070","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/BF00230974","article-title":"Dorsal raphe stimulation modifies striatal-evoked antidromic invasion of nigral dopaminergic neurons in vivo","volume":"84","author":"Trent","year":"1991","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4075","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0022-3565(25)12271-4","article-title":"The effects of clomipramine on the excitatory action of ethanol on dopaminergic neurons of the ventral tegmental area in vitro","volume":"276","author":"Trifunovic","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4080","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature11466","article-title":"Dopaminergic neurons inhibit striatal output through non-canonical release of GABA","volume":"490","author":"Tritsch","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4085","doi-asserted-by":"crossref","first-page":"e01936","DOI":"10.7554\/eLife.01936","article-title":"Midbrain dopamine neurons sustain inhibitory transmission using plasma membrane uptake of GABA, not synthesis","volume":"3","author":"Tritsch","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4090","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nbd.2013.08.014","article-title":"5-Hydroxy-tryptophan for the treatment of L-DOPA-induced dyskinesia in the rat Parkinson\u2019s disease model","volume":"60","author":"Tronci","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4095","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.bbr.2015.06.034","article-title":"Effect of selective and non-selective serotonin receptor activation on l-DOPA-induced therapeutic efficacy and dyskinesia in parkinsonian rats","volume":"292","author":"Tronci","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4100","first-page":"296","article-title":"Glutamate co-transmission as an emerging concept in monoamine neuron function","volume":"29","author":"Trudeau","year":"2004","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4105","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00442004","article-title":"Ritanserin a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition","volume":"98","author":"Ugedo","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00442004","article-title":"Ritanserin a 5-Ht2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition","volume":"98","author":"Ugedo","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4115","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/BF00178723","article-title":"Distribution of 5-HT4 receptor mRNA in the rat brain","volume":"354","author":"Ullmer","year":"1996","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4120","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/hipo.450050611","article-title":"Relational features of acetylcholine, noradrenaline, serotonin and GABA axon terminals in the stratum radiatum of adult rat hippocampus","volume":"5","author":"Umbriaco","year":"1995","journal-title":"Hippocampus"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4125","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejphar.2013.01.033","article-title":"Effects of serotonin-norepinephrine reuptake inhibitors on locomotion and prefrontal monoamine release in spontaneously hypertensive rats","volume":"702","author":"Umehara","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4130","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2796.1991.tb00459.x","article-title":"Microdialysis-principles and applications for studies in animals and man","volume":"230","author":"Ungerstedt","year":"1991","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4135","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1126\/science.1093360","article-title":"Uniform inhibition of dopamine neurons in the ventral tegmental area by aversive stimuli","volume":"303","author":"Ungless","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4140","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neubiorev.2010.04.006","article-title":"Effects of stress and aversion on dopamine neurons: implications for addiction","volume":"35","author":"Ungless","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4145","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neubiorev.2006.11.003","article-title":"The basal ganglia: an overview of circuits and function","volume":"32","author":"Utter","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4150","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1471-4159.2005.03030.x","article-title":"Selective serotonin reuptake blockade increases extracellular dopamine in noradrenaline-rich isocortical but not prefrontal areas: dependence on serotonin-1A receptors and independence from noradrenergic innervation","volume":"93","author":"Valentini","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4155","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.neuropharm.2010.12.006","article-title":"A microdialysis study of ST1936: a novel 5-HT6 receptor agonist","volume":"60","author":"Valentini","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4160","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/cne.1043","article-title":"Evidence for regional heterogeneity in corticotropin-releasing factor interactions in the dorsal raphe nucleus","volume":"435","author":"Valentino","year":"2001","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4165","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/cne.903340408","article-title":"Ultrastructure of serotonin-immunoreactive terminals in the core and shell of the rat nucleus accumbens: cellular substrates for interactions with catecholamine afferents","volume":"334","author":"Van Bockstaele","year":"1993","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4170","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0006-8993(93)90077-Z","article-title":"Topography of serotonin neurons in the dorsal raphe nucleus that send axon collaterals to the rat prefrontal cortex and nucleus accumbens","volume":"624","author":"Van Bockstaele","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4175","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0006-8993(94)91330-7","article-title":"Synaptic structure and connectivity of serotonin terminals in the ventral tegmental area: potential sites for modulation of mesolimbic dopamine neurons","volume":"647","author":"Van Bockstaele","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4180","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/S0024-3205(03)00141-3","article-title":"5-HT2A and 5-HT2C receptors and their atypical regulation properties","volume":"72","author":"Van Oekelen","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4185","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0165-6147(99)01432-7","article-title":"5-HT7 receptors: current knowledge and future prospects","volume":"21","author":"Vanhoenacker","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4190","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0006-8993(01)02823-2","article-title":"Autoradiographic mapping of 5-HT(1B) and 5-HT(1D) receptors in the post mortem human brain using [(3)H]GR 125743","volume":"915","author":"Varnas","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4195","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.neulet.2004.06.025","article-title":"Distribution of 5-HT7 receptors in the human brain: a preliminary autoradiographic study using [3H]SB-269970","volume":"367","author":"Varnas","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4200","first-page":"1678","article-title":"Pyramidal neurons in rat prefrontal cortex projecting to ventral tegmental area and dorsal raphe nucleus express 5-HT2A receptors","volume":"19","author":"Vazquez-Borsetti","year":"2009","journal-title":"Cereb. Cortex (New York, N.Y.: 1991)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4205","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1017\/S1461145710000349","article-title":"Simultaneous projections from prefrontal cortex to dopaminergic and serotonergic nuclei","volume":"14","author":"Vazquez-Borsetti","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4210","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1523\/JNEUROSCI.06-12-03474.1986","article-title":"Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5, 7-dihydroxytryptamine-treated rats","volume":"6","author":"Verge","year":"1986","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4215","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0169-328X(96)00248-3","article-title":"Localization of 5-HT4 receptor mRNA in rat brain by in situ hybridization histochemistry","volume":"43","author":"Vilaro","year":"1996","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4220","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/cne.20447","article-title":"Serotonin 5-HT4 receptors and their mRNAs in rat and guinea pig brain: distribution and effects of neurotoxic lesions","volume":"484","author":"Vilaro","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4225","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/cne.20447","article-title":"Serotonin 5-HT4 receptors and their mRNAs in rat and guinea pig brain: distribution and effects of neurotoxic lesions","volume":"484","author":"Vilaro","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4230","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuint.2014.12.006","article-title":"Serotonin-2C antagonism augments the effect of citalopram on serotonin and dopamine levels in the ventral tegmental area and nucleus accumbens","volume":"81","author":"Visser","year":"2015","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4235","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0022-3565(25)12057-0","article-title":"Effect of the 5-hydroxytryptamine3 receptor antagonist itasetron (DAU 6215) on (+)-N-allylnormetazocine-induced dopamine release in the nucleus accumbens and in the corpus striatum of the rat: an in vivo microdialysis study","volume":"275","author":"Volonte","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4240","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1046\/j.1471-4159.1997.69010182.x","article-title":"BIMG 80: a novel potential antipsychotic drug: evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex","volume":"69","author":"Volonte","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4245","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.1471-4159.1994.63010108.x","article-title":"L-3, 4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors","volume":"63","author":"Wachtel","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4250","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF02244220","article-title":"Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia","volume":"101","author":"Waddington","year":"1990","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4255","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0028-3908(98)00162-2","article-title":"Effects of local application of 5-hydroxytryptamine into the dorsal or median raphe nuclei on haloperidol-induced catalepsy in the rat","volume":"38","author":"Wadenberg","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4260","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0306-4522(89)90082-1","article-title":"Serotonin-1 receptor binding sites in the human basal ganglia are decreased in Huntington\u2019s chorea but not in Parkinson\u2019s disease: a quantitative in vitro autoradiography study","volume":"32","author":"Waeber","year":"1989","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4265","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1097\/00001756-199309000-00007","article-title":"[3H]-GR113808 labels 5-HT4 receptors in the human and guinea-pig brain","volume":"4","author":"Waeber","year":"1993","journal-title":"Neuroreport"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4270","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1749-6632.1998.tb10177.x","article-title":"Putative 5-ht5 receptors: localization in the mouse CNS and lack of effect in the inhibition of dural protein extravasation","volume":"861","author":"Waeber","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4275","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0014-2999(79)90110-9","article-title":"Serotonin\u2013dopamine interactions in the nigrostriatal system","volume":"55","author":"Waldmeier","year":"1979","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4280","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1523\/JNEUROSCI.0312-09.2009","article-title":"Response disengagement on a spatial self-ordered sequencing task: effects of regionally selective excitotoxic lesions and serotonin depletion within the prefrontal cortex","volume":"29","author":"Walker","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4285","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.neuroscience.2009.04.069","article-title":"The firing activity of pyramidal neurons in medial prefrontal cortex and their response to 5-hydroxytryptamine-1A receptor stimulation in a rat model of Parkinson\u2019s disease","volume":"162","author":"Wang","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4290","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.neuroscience.2008.12.051","article-title":"Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT(1A) receptor stimulation in the rat","volume":"159","author":"Wang","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4295","series-title":"Neuroscience Meeting Planner","article-title":"Dorsal raphe excitatory drive on vta dopamine neurons","author":"Wang","year":"2012"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4300","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/(SICI)1096-9861(19960701)370:3<405::AID-CNE10>3.0.CO;2-R","article-title":"Colocalization of serotonin receptor subtypes 5-HT2A 5-HT2C, and 5-HT6 with neuropeptides in rat striatum","volume":"370","author":"Ward","year":"1996","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4305","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.neuron.2012.03.017","article-title":"Whole-brain mapping of direct inputs to midbrain dopamine neurons","volume":"74","author":"Watabe-Uchida","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4310","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-2999(96)00150-1","article-title":"Ipsapirone enhances the dopamine outflow via 5-HT1A receptors in the rat prefrontal cortex","volume":"305","author":"Wedzony","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4315","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0304-3940(82)90153-7","article-title":"Inhibition of the electrically induced release of [3H]dopamine by serotonin from superfused rat striatal slices","volume":"28","author":"Westfall","year":"1982","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4320","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0026-895X(25)10237-X","article-title":"Increased basal phosphorylation of the constitutively active serotonin 2C receptor accompanies agonist-mediated desensitization","volume":"48","author":"Westphal","year":"1995","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4325","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev.ne.19.030196.002201","article-title":"Synaptic regulation of mesocorticolimbic dopamine neurons","volume":"19","author":"White","year":"1996","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4330","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.2042-7158.1983.tb02880.x","article-title":"The involvement of 5-hydroxytryptamine in the release of dendritic dopamine from slices of rat substantia nigra","volume":"35","author":"Williams","year":"1983","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4335","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0006-8993(97)01267-5","article-title":"Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens","volume":"781","author":"Willins","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4340","first-page":"19","article-title":"Animal models of depression: validity and applications","volume":"49","author":"Willner","year":"1995","journal-title":"Adv. Biochem. Psychopharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4345","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/cne.903510304","article-title":"Comparative localization of serotonin, (1a), (1c) and (2) receptor subtype messenger-Rnas in rat-brain","volume":"351","author":"Wright","year":"1995","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4350","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.bcp.2013.07.013","article-title":"Cortical control of VTA function and influence on nicotine reward","volume":"86","author":"Wu","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4355","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0022-3565(25)22522-8","article-title":"Endogenous serotonin stimulates striatal dopamine release in conscious rats","volume":"270","author":"Yadid","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4360","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1111\/ejn.12359","article-title":"Glutamate neurons in the substantia nigra compacta and retrorubral field","volume":"38","author":"Yamaguchi","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4365","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0022-3565(25)09555-2","article-title":"Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra","volume":"273","author":"Yamamoto","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4370","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/00001756-200105080-00015","article-title":"Fluoxetine reduces L-DOPA-derived extracellular DA in the 6-OHDA-lesioned rat striatum","volume":"12","author":"Yamato","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4375","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(01)00913-X","article-title":"Activation of 5-HT(1B\/1D) receptors in the mesolimbic dopamine system increases dopamine release from the nucleus accumbens: a microdialysis study","volume":"418","author":"Yan","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4380","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1046\/j.1471-4159.2001.00643.x","article-title":"Serotonin-1B receptor-mediated inhibition of [(3)H]GABA release from rat ventral tegmental area slices","volume":"79","author":"Yan","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4385","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.brainres.2004.06.053","article-title":"Involvement of 5-HT1B receptors within the ventral tegmental area in regulation of mesolimbic dopaminergic neuronal activity via GABA mechanisms: a study with dual-probe microdialysis","volume":"1021","author":"Yan","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4390","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.brainres.2005.08.051","article-title":"Involvement of 5-HT1B receptors within the ventral tegmental area in ethanol-induced increases in mesolimbic dopaminergic transmission","volume":"1060","author":"Yan","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4395","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0361-9230(99)00208-7","article-title":"Activation of 5-HT2A\/2C receptors within the nucleus accumbens increases local dopaminergic transmission","volume":"51","author":"Yan","year":"2000","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4400","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0091-3057(95)00068-8","article-title":"Serotonergic stimulation of the ventrolateral striatum induces orofacial stereotypy","volume":"52","author":"Yeghiayan","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4405","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0091-3057(96)00217-1","article-title":"Role of dopamine in behavioral effects of serotonin microinjected into rat striatum","volume":"56","author":"Yeghiayan","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4410","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0014-2999(91)90456-Z","article-title":"Effect of cocaine and 5-HT3 receptor antagonists on 5-HT-induced [3H]dopamine release from rat striatal synaptosomes","volume":"199","author":"Yi","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4415","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF00969884","article-title":"Regulation of nucleus accumbens dopamine release by the dorsal raphe nucleus in the rat","volume":"17","author":"Yoshimoto","year":"1992","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4420","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0197-0186(01)00079-1","article-title":"Tandospirone potentiates the fluoxetine-induced increases in extracellular dopamine via 5-HT(1A) receptors in the rat medial frontal cortex","volume":"40","author":"Yoshino","year":"2002","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4425","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neulet.2004.03.079","article-title":"Perospirone a novel atypical antipsychotic drug, potentiates fluoxetine-induced increases in dopamine levels via multireceptor actions in the rat medial prefrontal cortex","volume":"364","author":"Yoshino","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4430","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s002130100746","article-title":"Association between depressive behavior and absence of serotonin-dopamine interaction in the nucleus accumbens","volume":"155","author":"Zangen","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4435","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00213-010-1996-3","article-title":"Blockade of nucleus accumbens 5-HT2A and 5-HT2C receptors prevents the expression of cocaine-induced behavioral and neurochemical sensitization in rats","volume":"213","author":"Zayara","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4440","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1476-5381.1994.tb17087.x","article-title":"Role of 5-HT3 receptors in basal and K(+)-evoked dopamine release from rat olfactory tubercle and striatal slices","volume":"113","author":"Zazpe","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4445","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0893-133X(00)00119-6","article-title":"Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex","volume":"23","author":"Zhang","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4450","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/sj.mp.4001052","article-title":"Association of a polymorphism in the promoter region of the serotonin 5-HT2C receptor gene with tardive dyskinesia in patients with schizophrenia","volume":"7","author":"Zhang","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4455","doi-asserted-by":"crossref","first-page":"12366","DOI":"10.1523\/JNEUROSCI.5411-11.2012","article-title":"Impact of prefrontal cortex in nicotine-induced excitation of ventral tegmental area dopamine neurons in anesthetized rats","volume":"32","author":"Zhang","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4460","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fncel.2015.00388","article-title":"Decrease of gene expression of astrocytic 5-HT2B receptors parallels development of depressive phenotype in a mouse model of Parkinson\u2019s disease","volume":"9","author":"Zhang","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4465","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0006-8993(02)02709-9","article-title":"Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative","volume":"942","author":"Zhou","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4470","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neuron.2005.02.010","article-title":"Corelease of dopamine and serotonin from striatal dopamine terminals","volume":"46","author":"Zhou","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4475","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.bcp.2006.09.008","article-title":"Evidence for significant contribution of a newly identified monoamine transporter (PMAT) to serotonin uptake in the human brain","volume":"73","author":"Zhou","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4480","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0031-6997(25)00462-4","article-title":"5-Hydroxytryptamine receptors","volume":"44","author":"Zifa","year":"1992","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4485","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neulet.2005.06.035","article-title":"Aripiprazole increases dopamine but not noradrenaline and serotonin levels in the mouse prefrontal cortex","volume":"387","author":"Zocchi","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4490","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1212\/WNL.45.7.1305","article-title":"Psychosis in advanced Parkinson\u2019s disease: treatment with ondansetron a 5-HT3 receptor antagonist","volume":"45","author":"Zoldan","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4495","first-page":"541","article-title":"Ondansetron: a 5-HT3 antagonist for visual hallucinations and paranoid delusional disorder associated with chronic L-DOPA therapy in advanced Parkinson\u2019s disease","volume":"69","author":"Zoldan","year":"1996","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4500","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2165\/00023210-200620120-00003","article-title":"Agomelatine: a preliminary review of a new antidepressant","volume":"20","author":"Zupancic","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4505","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1471-4159.1980.tb07879.x","article-title":"Presynaptic control of the synthesis and release of dopamine from striatal synaptosomes: a comparison between the effects of 5-hydroxytryptamine acetylcholine, and glutamate","volume":"35","author":"de Belleroche","year":"1980","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4510","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0922-4106(90)90190-9","article-title":"The concept of selectivity in 5-HT receptor research","volume":"188","author":"van Wijngaarden","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.03.004_bib4515","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/0006-8993(80)90905-1","article-title":"Bilaterally situated dorsal raphe cell bodies have only unilateral forebrain projections in rat","volume":"192","author":"van der Kooy","year":"1980","journal-title":"Brain Res."}],"container-title":["Progress in Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008215300964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008215300964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T18:12:12Z","timestamp":1748801532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301008215300964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":903,"alternative-id":["S0301008215300964"],"URL":"https:\/\/doi.org\/10.1016\/j.pneurobio.2016.03.004","relation":{},"ISSN":["0301-0082"],"issn-type":[{"value":"0301-0082","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Progress in Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pneurobio.2016.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}